Keywords
Last Name
Institution

M ZOUHAIR ATASSI

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Biochemistry & Molecular Biology
AddressOne Baylor Plaza
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Pathology & Immunology
    DivisionImmunology


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Biography 
    Collapse awards and honors
    1966 - 1971Established Investigator , American Heart Association
    1973Doctor of Science (D.Sc.), University of Birmingham, England
    1979Distinguished Lecturer in Medical Science, Mayo Grad. Sch. of Medicine
    1984Wellcome Professorship in Basic Medical Sciences, University of Mississippi, Oxford, MS, Borough-Wellcome and FASEB
    1987The Harden Medal, The Biochemical Society, London
    1987Jubilee Lecture, The Biochemical Society, London
    1987Distinguished Lecturer, State University of New York at Buffalo, Health Sciences Center
    1991Distinguished Lecturer in Immunology, University of Texas Health Science Center, Galveston, Texas
    1992Chairman of the 1994 International Conference on Methods in Protein Structure Analysis , Methods of Protein Structure Analysis (MPSA)
    1992 - 2002Member, Edman Award Selection Committee, Methods of Protein Structure Analysis (MPSA)
    1995The Kuwait Prize in Basic Science, Kuwait Foundation for the Advancement of Science
    2003 - 2014President, Institute of Immunobiology
    2006Chairman, International Conference on Neurotoxins, The Neurotoxin Institute
    2006 - 2009President, International Symposium of Immunobiology
    2007 - 2012Member of the Selection Committee , King Faisal International Prize
    2011 - 2015Member, Board of Directors, International Neurotoxin Association

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Oshima M, Deitiker P, Jankovic J, Aoki KR, Atassi MZ. Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. Journal of Neuroimmunology DOI: 10.1016/j. 2016; 300:36-46.
    2. Oshima M, Deitiker P, Jankovic J, Aoki KR, Atassi MZ. Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. Immunobiology. 2016; 221(4):568-576.
    3. Oshima M, Deitiker P, Jankovic J, Aoki KR, Atassi MZ. Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. Immunobiology. 2016 Apr; 221(4):568-76. PMID: 26701846.
      View in: PubMed
    4. Ayyar BV, Tajhya RB, Beeton C, Atassi MZ. Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin. Sci Rep. 2015 Oct 28;5:15776. doi: 10.1038/srep15776. 2015; 5:15776.
    5. Vijayalakshmi Ayyar B, Tajhya RB, Beeton C, Zouhair Atassi M. Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin. Sci Rep. 2015; 5:15776. PMID: 26508475.
      View in: PubMed
    6. Atassi MZ. Molecular basis of immunogenicity to botulinum neurotoxins and uses of the defined antigenic regions. Toxicon. 2015 Jun 16. PMID: 26086358.
      View in: PubMed
    7. Ayyar BV, Aoki KR, Atassi MZ. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions. Infection and Immunity. 2015; 83(4):1465-76.
    8. Atassi MZ, Casali P. J. Clin Cell Immunol. Analysis: Autoimmune Disorders: An Overview of Molecular and Cellular Basis in Today’s Perspective. 2015; 6(1):1000302.
    9. Deitiker P, Atassi MZ. MHC Genes Linked to Autoimmune Disease. Crit Rev Immunol. 2015; 35(3):203-251.
    10. Deitiker P, Atassi MZ. MHC Genes Linked to Autoimmune Disease. Crit Rev Immunol. 2015; 35(3):203-51. PMID: 26559228.
      View in: PubMed
    11. Oshima M, Aoki KR, Atassi MZ. . Regions recognized on the light chain of botulinum neurotoxin type A by T lymphocytes of SJL and BALB/c mice primed with inactivated toxin. Immunobiology. 2014; 219(Dec 12):950-957.
    12. Oshima M, Aoki KR, Atassi MZ. Regions recognized on the light chain of botulinum neurotoxin type A by T lymphocytes of SJL and BALB/c mice primed with inactivated toxin. Immunobiology. 2014 Dec; 219(12):950-7. PMID: 25151501.
      View in: PubMed
    13. Atassi MZ, Taruishi M, Naqvi M, Steward LE, Aoki KR. Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other. Protein J. 2014 Jun; 33(3):278-88. PMID: 24740609.
      View in: PubMed
    14. Atassi MZ, Naqvi M, Dolimbek BZ, Aoki KR. Reduction of established antibody responses against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol peptide conjugates. J Neuroimmunol. 2014 Jul 15; 272(1-2):29-34. PMID: 24841626.
      View in: PubMed
    15. Atassi MZ, Taruishi M, Naqvi M, Steward LE, Aoki KR. Synaptotagmin II and Gangliosides Bind Independently with Botulinum Neurotoxin B but Each Restrains the Other. The Protein J. 2014.
    16. Eichhorn T, Dolimbek BZ, Deeg K, Efferth T, Atassi MZ. Inhibition in vivo of the activity of botulinum neurotoxin A by small molecules selected by virtual screening. Toxicon. 2012 Nov; 60(6):1180-90. PMID: 22960451.
      View in: PubMed
    17. Deitiker P, Atassi MZ. Non-MHC genes linked to autoimmune disease. Crit Rev Immunol. 2012; 3(32):193-285.
    18. Dolimbek BZ, Steward LE, Aoki KR, Atassi MZ. Location of the synaptosome-binding regions on botulinum neurotoxin B. Biochemistry. 2012 Jan 10; 51(1):316-28. PMID: 22146011.
      View in: PubMed
    19. Atassi MZ, Dolimbek BZ, Steward LE, Aoki KR. Antibodies against a synthetic peptide designed to mimic a surface area of the H chain of botulinum neurotoxin A. Immunol Lett. 2012 Feb 29; 142(1-2):20-7. PMID: 22123395.
      View in: PubMed
    20. Oshima M, Deitiker PR, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B. J Neuroimmunol. 2011 Dec 15; 240-241:121-8. PMID: 22079193.
      View in: PubMed
    21. Oshima M, Deitiker PR, Smith RG, Mosier D, Atassi MZ. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients. Autoimmunity. 2012 Mar; 45(2):153-60. PMID: 21985279.
      View in: PubMed
    22. Atassi MZ, Oshima M, Dolimbek BZ, Aoki KR. Antibody and T cell recognition of the light chain of botulinum neurotoxin A in two high-responder mouse strains. Immunobiology. 2012 Jan; 217(1):1-7. PMID: 22015045.
      View in: PubMed
    23. Atassi MZ, Jankovic J, Steward LE, Aoki KR, Dolimbek BZ. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule. Immunobiology. 2012 Jan; 217(1):17-27. PMID: 21962573.
      View in: PubMed
    24. Atassi MZ, Deitiker PR. Does Clostridium botulinum neurotoxin A exhibit molecular mimicry with thyroid autoantigens and cause thyroid complications in predisposed persons? Endocrine. 2011 Aug; 40(1):140-1; author reply 142-3. PMID: 21541651.
      View in: PubMed
    25. Oshima M, Deitiker PR, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patients. J Neuroimmunol. 2011 Aug 15; 237(1-2):66-72. PMID: 21737146.
      View in: PubMed
    26. Dolimbek BZ, Aoki KR, Atassi MZ. Reduction of antibody response against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol-peptide conjugates. Immunol Lett. 2011 Jun 30; 137(1-2):46-52. PMID: 21324340.
      View in: PubMed
    27. Atassi MZ, Bonavida B. COMMENTARY: Clinical Applications of Photodynamic Therapy. Forum Immunopathological Diseases and Therapeutics. 2011; 2(3):273-276.
    28. Bonavida B, Atassi MZ. COMMENTARY: Molecular and Biochemical Mechanisms of Photodynamic Therapy Anti-Tumor Effects. Forum on Immunopathological Diseases and Therapeutics. 2011; 2(3):141-143.
    29. Atassi MZ, Dolimbek BZ, Jankovic J, Steward LE, Aoki KR. Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies. Immunobiology. 2011 Jul; 216(7):782-92. PMID: 21281977.
      View in: PubMed
    30. Deitiker PR, Oshima M, Smith RG, Mosier D, Atassi MZ. Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States. Int J Immunogenet. 2011 Feb; 38(1):55-62. PMID: 21108743.
      View in: PubMed
    31. Dolimbek BZ, Steward LE, Aoki KR, Atassi MZ. Regions of recognition by blocking antibodies on the light chain of botulinum neurotoxin A: antigenic structure of the entire toxin. Immunobiology. 2011 Jun; 216(6):698-706. PMID: 21183243.
      View in: PubMed
    32. Deitiker PR, Oshima M, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans. Autoimmunity. 2011 May; 44(3):167-76. PMID: 20843162.
      View in: PubMed
    33. Atassi MZ, Dolimbek BZ, Steward LE, Aoki KR. Inhibition of botulinum neurotoxin a toxic action in vivo by synthetic synaptosome- and blocking antibody-binding regions. Protein J. 2010 Jul; 29(5):320-7. PMID: 20571899.
      View in: PubMed
    34. Efferth T, Yeung KC, Umezawa K, Atassi MZ. COMMENTARY. Biochemistry and Gene regulation of YY1. Forum on Immunopathological Diseases and Therapeutics. 2010; 1(1-2):141-143.
    35. Aoki KR, Smith LA, Atassi MZ. Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognition. Crit Rev Immunol. 2010; 30(2):167-87. PMID: 20370628.
      View in: PubMed
    36. Atassi MZ. Immune recognition of BoNTs A and B: how anti-toxin antibodies that bind to the heavy chain obstruct toxin action. Toxicon. 2009 Oct; 54(5):600-13. PMID: 19285100.
      View in: PubMed
    37. Atassi MZ, Jankovic J, Dolimbek BZ. Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A. Neurology. 2008 Sep 23; 71(13):1040; author reply 1040-1. PMID: 18809844.
      View in: PubMed
    38. Dolimbek BZ, Steward LE, Aoki KR, Atassi MZ. The binding sites on botulinum neurotoxin B for synaptotagmin and for blocking antibodies. Biochem Biophys Res Commun. 2008 Nov 21; 376(3):631-2. PMID: 18796292.
      View in: PubMed
    39. Atassi MZ, Dolimbek BZ, Jankovic J, Steward LE, Aoki KR. Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment. Mol Immunol. 2008 Sep; 45(15):3878-88. PMID: 18676021.
      View in: PubMed
    40. Atassi MZ, Casali P. Molecular mechanisms of autoimmunity. Autoimmunity. 2008 Mar; 41(2):123-32. PMID: 18324481.
      View in: PubMed
    41. Dolimbek BZ, Steward LE, Aoki KR, Atassi MZ. Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin. Mol Immunol. 2008 Feb; 45(4):910-24. PMID: 17897717.
      View in: PubMed
    42. Atassi MZ, Schluter SF, Adelman MK. Dedication: John Jacob "Jack" Marchalonis, PhD, 1940-2007. Crit Rev Immunol. 2007; 27(3):v-vi. PMID: 18197816.
      View in: PubMed
    43. Atassi MZ. Preface: Immunology of protein and peptide therapies. Crit Rev Immunol. 2007; 27(3):vii-viii. PMID: 18197817.
      View in: PubMed
    44. Oshima M, Deitiker P, Atassi MZ. Targeting the antigen-binding site of HLA-restricting alleles in treatment of autoimmune disease. Crit Rev Immunol. 2007; 27(3):271-88. PMID: 18197821.
      View in: PubMed
    45. Atassi MZ, Dolimbek BZ, Steward LE, Aoki KR. Molecular bases of protective immune responses against botulinum neurotoxin A--how antitoxin antibodies block its action. Crit Rev Immunol. 2007; 27(4):319-41. PMID: 18197812.
      View in: PubMed
    46. Atassi MZ, Dolimbek BZ, Deitiker P, Jankovic J, Aoki KR. A peptide-based immunoassay for antibodies against botulinum neurotoxin A. J Mol Recognit. 2007 Jan-Feb; 20(1):15-21. PMID: 16981247.
      View in: PubMed
    47. Jankovic J, Hunter C, Dolimbek BZ, Dolimbek GS, Adler CH, Brashear A, Comella CL, Gordon M, Riley DE, Sethi K, Singer C, Stacy M, Tarsy D, Atassi MZ. Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia. Neurology. 2006 Dec 26; 67(12):2233-5. PMID: 17190952.
      View in: PubMed
    48. Atassi MZ. On the enhancement of anti-neurotoxin antibody production by subcomponents HA1 and HA3b of Clostridium botulinum type B 16S toxin-haemagglutinin. Microbiology. 2006 Jul; 152(Pt 7):1891-5; discussion 1895-7. PMID: 16804163.
      View in: PubMed
    49. Deitiker PR, Oshima M, Smith RG, Mosier DR, Atassi MZ. Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity. 2006 Jun; 39(4):277-88. PMID: 16891216.
      View in: PubMed
    50. Jha S, Xu K, Maruta T, Oshima M, Mosier DR, Atassi MZ, Hoch W. Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK). J Neuroimmunol. 2006 Jun; 175(1-2):107-17. PMID: 16697051.
      View in: PubMed
    51. Dolimbek BZ, Aoki KR, Steward LE, Jankovic J, Atassi MZ. Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A. Mol Immunol. 2007 Feb; 44(5):1029-41. PMID: 16647121.
      View in: PubMed
    52. Maruta T, Dolimbek BZ, Aoki KR, Atassi MZ. Inhibition by human sera of botulinum neurotoxin-A binding to synaptosomes: a new assay for blocking and non-blocking antibodies. J Neurosci Methods. 2006 Mar 15; 151(2):90-6. PMID: 16466805.
      View in: PubMed
    53. Maruta T, Oshima M, Deitiker PR, Ohtani M, Atassi MZ. Use of alum and inactive Bordetella pertussis for generation of antibodies against synthetic peptides in mice. Immunol Invest. 2006; 35(2):137-48. PMID: 16698673.
      View in: PubMed
    54. Oshima M, Maruta T, Ohtani M, Deitiker PR, Mosier D, Atassi MZ. Vaccination with a MHC class II peptide in Alum and inactive pertussis strongly ameliorates clinical MG in C57BL/6 mice. J Neuroimmunol. 2006 Feb; 171(1-2):8-16. PMID: 16271400.
      View in: PubMed
    55. Atassi MZ, Dolimbek GS, Deitiker PR, Aoki KR, Dolimbek BZ. Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A. Mol Immunol. 2005 Aug; 42(12):1509-20. PMID: 15950744.
      View in: PubMed
    56. Oshima M, Ohtani M, Deitiker PR, Smith RG, Mosier DR, Atassi MZ. Suppression by mAbs against DQB1 peptides of in vitro proliferation of AChR-specific T cells from myasthenia gravis patients. Autoimmunity. 2005 Mar; 38(2):161-9. PMID: 16040337.
      View in: PubMed
    57. Atassi MZ, Childress C. Immunogenicity of heme complexes of peptides designed to mimic the heme environment of myoglobin and hemoglobin. Protein J. 2005 Jan; 24(1):51-6. PMID: 15756817.
      View in: PubMed
    58. Dolimbek GS, Dolimbek BZ, Aoki KR, Atassi MZ. Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449-859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains. Immunol Invest. 2005; 34(2):119-42. PMID: 15921155.
      View in: PubMed
    59. Atassi MZ, Childress C. Oxygen-binding heme complexes of peptides designed to mimic the heme environment of myoglobin and hemoglobin. Protein J. 2005 Jan; 24(1):37-49. PMID: 15756816.
      View in: PubMed
    60. Oshima M, Deitiker PR, Mosier DR, Smith RG, Atassi MZ. Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor alpha-chain peptides: analysis in relation to age, thymic abnormality, and ethnicity. Hum Immunol. 2005 Jan; 66(1):32-42. PMID: 15620460.
      View in: PubMed
    61. Maruta T, Dolimbek BZ, Aoki KR, Steward LE, Atassi MZ. Mapping of the synaptosome-binding regions on the heavy chain of botulinum neurotoxin A by synthetic overlapping peptides encompassing the entire chain. Protein J. 2004 Nov; 23(8):539-52. PMID: 15648976.
      View in: PubMed
    62. Atassi MZ. Basic immunological aspects of botulinum toxin therapy. Mov Disord. 2004 Mar; 19 Suppl 8:S68-84. PMID: 15027058.
      View in: PubMed
    63. Atassi MZ, Dolimbek BZ. Mapping of the antibody-binding regions on the HN-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A. Protein J. 2004 Jan; 23(1):39-52. PMID: 15115181.
      View in: PubMed
    64. Dolimbek BZ, Jankovic J, Atassi MZ. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response. Immunol Invest. 2002 Aug-Nov; 31(3-4):247-62. PMID: 12472183.
      View in: PubMed
    65. Oshima M, Deitiker P, Ashizawa T, Atassi MZ. Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG. Autoimmunity. 2002 May; 35(3):183-90. PMID: 12389643.
      View in: PubMed
    66. Atassi MZ. Scientific and Therapeutic Aspects of Botulinum Toxins (edited by Brin MF, Hallett M, Jankovic J). Immune recognition and cross-reactivity of botulinum neurotoxins. 2002; 385-408.
    67. Atassi MZ, Oshima M, Deitiker P. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Crit Rev Immunol. 2001; 21(1-3):1-27. PMID: 11642597.
      View in: PubMed
    68. Nakayashiki N, Oshima M, Deitiker PR, Ashizawa T, Atassi MZ. Suppression of experimental myasthenia gravis by monoclonal antibodies against MHC peptide region involved in presentation of a pathogenic T-cell epitope. J Neuroimmunol. 2000 Jun 26; 105(2):131-44. PMID: 10742555.
      View in: PubMed
    69. Deitiker P, Ashizawa T, Atassi MZ. Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of Myasthenia gravis? Hum Immunol. 2000 Mar; 61(3):255-65. PMID: 10689115.
      View in: PubMed
    70. Oshima M, Atassi MZ. T cells of mice treated with mPEG-myasthenogenic peptide conjugate are involved in protection against EAMG by stimulating lower pathogenic antibody responses. Autoimmunity. 2000; 32(1):45-55. PMID: 10958175.
      View in: PubMed
    71. Yoshioka N, Atassi MZ. Subunit interacting surfaces of human hemoglobin in solution: localization of the alpha-beta subunit interacting surfaces on the alpha-chain by a comprehensive synthetic strategy. J Protein Chem. 1999 Feb; 18(2):179-85. PMID: 10333291.
      View in: PubMed
    72. Atassi MZ, Oshima M. Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins. Crit Rev Immunol. 1999; 19(3):219-60. PMID: 10422600.
      View in: PubMed
    73. Abaza MS, Shaban FA, Narayan RK, Atassi MZ. In vitro inhibition of human malignant brain tumour cell line proliferation by anti-urokinase-type plasminogen activator monoclonal antibodies. Br J Cancer. 1998 Dec; 78(12):1578-85. PMID: 9862567; PMCID: PMC2063246.
    74. Atassi MZ, Yoshioka N. Mapping of the subunit interacting surfaces of oligomeric proteins in solution by a comprehensive synthetic strategy. J Protein Chem. 1998 Aug; 17(6):553-5. PMID: 9723756.
      View in: PubMed
    75. Hamajima S, Atassi MZ. B-cell activation in vitro by helper T cells specific to a protein region that is recognized both by T cells and by antibodies. Immunol Invest. 1998 May; 27(3):121-34. PMID: 9653661.
      View in: PubMed
    76. Abaza MS, Shaban F, Narayan RK, Atassi MZ. Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity. Anticancer Res. 1998 Mar-Apr; 18(2B):1333-40. PMID: 9615812.
      View in: PubMed
    77. Oshima M, Yokoi T, Deitiker P, Atassi MZ. T cell responses in EAMG-susceptible and non-susceptible mouse strains after immunization with overlapping peptides encompassing the extracellular part of Torpedo californica acetylcholine receptor alpha chain. Implication to role in myasthenia gravis of autoimmune T-cell responses against receptor degradation products. Autoimmunity. 1998; 27(2):79-90. PMID: 9583739.
      View in: PubMed
    78. Abaza MS, Narayan RK, Atassi MZ. Anti-urokinase-type plasminogen activator monoclonal antibodies inhibit the proliferation of human breast cancer cell lines in vitro. Tumour Biol. 1998; 19(4):229-37. PMID: 9679732.
      View in: PubMed
    79. Oshima M, Middlebrook JL, Atassi MZ. Antibodies and T cells against synthetic peptides of the C-terminal domain (Hc) of botulinum neurotoxin type A and their cross-reaction with Hc. Immunol Lett. 1998 Jan; 60(1):7-12. PMID: 9541456.
      View in: PubMed
    80. Abaza MS, Narayan RK, Atassi MZ. In vitro efficacy of anti-glial fibrillary acidic protein monoclonal antibodies against human malignant glioma cell lines. Jpn J Cancer Res. 1997 Nov; 88(11):1094-9. PMID: 9439685.
      View in: PubMed
    81. Oshima M, Hayakari M, Middlebrook JL, Atassi MZ. Immune recognition of botulinum neurotoxin type A: regions recognized by T cells and antibodies against the protective H(C) fragment (residues 855-1296) of the toxin. Mol Immunol. 1997 Oct; 34(14):1031-40. PMID: 9488054.
      View in: PubMed
    82. Rosenberg JS, Middlebrook JL, Atassi MZ. Localization of the regions on the C-terminal domain of the heavy chain of botulinum A recognized by T lymphocytes and by antibodies after immunization of mice with pentavalent toxoid. Immunol Invest. 1997 Jun; 26(4):491-504. PMID: 9246568.
      View in: PubMed
    83. Rosenberg JS, Atassi MZ. Intersite helper function of T cells specific for a protein epitope that is not recognized by antibodies. Immunol Invest. 1997 Jun; 26(4):473-89. PMID: 9246567.
      View in: PubMed
    84. Atassi MZ, Oshima M. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides. Crit Rev Immunol. 1997; 17(5-6):481-95. PMID: 9419435.
      View in: PubMed
    85. Rosenberg JS, Oshima M, Atassi MZ. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor. J Immunol. 1996 Oct 1; 157(7):3192-9. PMID: 8816433.
      View in: PubMed
    86. Atassi MZ, Dolimbek BZ, Hayakari M, Middlebrook JL, Whitney B, Oshima M. Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species. J Protein Chem. 1996 Oct; 15(7):691-700. PMID: 8968960.
      View in: PubMed
    87. Dolimbek BZ, Atassi MZ. Protection against alpha-bungarotoxin poisoning by immunization with synthetic toxin peptides. Mol Immunol. 1996 May-Jun; 33(7-8):681-9. PMID: 8760280.
      View in: PubMed
    88. Atassi MZ, Dolimbek BZ, Manshouri T. Antibody and T-cell recognition of alpha-bungarotoxin and its synthetic loop-peptides. Mol Immunol. 1995 Aug; 32(12):919-29. PMID: 7565818.
      View in: PubMed
    89. Simeckova-Rosenberg J, Yun Z, Wyde PR, Atassi MZ. Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin. Vaccine. 1995 Jul; 13(10):927-32. PMID: 7483766.
      View in: PubMed
    90. Oshima M, Atassi MZ. Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162. J Immunol. 1995 May 15; 154(10):5245-54. PMID: 7537303.
      View in: PubMed
    91. Atassi MZ, Oshima M. Autoimmune recognition of acetylcholine receptor and manipulation of the autoimmune responses by synthetic peptides. Adv Exp Med Biol. 1995; 383:141-56. PMID: 8644499.
      View in: PubMed
    92. Atassi MZ, Dolimbek BZ. Methods in Protein Structure Analysis (Edited by Atassi MZ, Appella E). Regions of Interaction between Nicotinic Acetylcholine Receptor and ?-Neurotoxins and Development of a Synthetic Vaccine Against Toxin Poisoning. 1995; 311–326 .
    93. Jinnai K, Ashizawa T, Atassi MZ. Analysis of exposed regions on the main extracellular domain of mouse acetylcholine receptor alpha subunit in live muscle cells by binding profiles of antipeptide antibodies. J Protein Chem. 1994 Nov; 13(8):715-22. PMID: 7710661.
      View in: PubMed
    94. Oshima M, Pachner AR, Atassi MZ. Profile of the regions of acetylcholine receptor alpha chain recognized by T-lymphocytes and by antibodies in EAMG-susceptible and non-susceptible mouse strains after different periods of immunization with the receptor. Mol Immunol. 1994 Aug; 31(11):833-43. PMID: 7519305.
      View in: PubMed
    95. Atassi MZ, Mulac-Jericevic B, Ashizawa T. Mapping of the polypeptide chain organization of the main extracellular domain of the alpha-subunit in membrane-bound acetylcholine receptor by antipeptide antibodies spanning the entire domain. Adv Exp Med Biol. 1994; 347:221-8. PMID: 7526636.
      View in: PubMed
    96. Atassi MZ. Molecular recognition of acetylcholine receptor. Recognition by alpha-neurotoxins and by immune and autoimmune responses and manipulation of the responses. Adv Neuroimmunol. 1994; 4(4):403-32. PMID: 7536603.
      View in: PubMed
    97. Atassi MZ, Bixler GS. Synthetic Vaccines (Edited by Nicholson B). Perspectives from Immune Recognition of Discontinuous Sites. 1994; 93–115.
    98. Christadoss P, Shenoy M, Oshima M, Atassi MZ. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance. Adv Exp Med Biol. 1994; 347:65-75. PMID: 7976734.
      View in: PubMed
    99. Atassi MZ, Mulac-Jericevic B. Mapping the extracellular topography of the alpha-chain in free and in membrane-bound acetylcholine receptor by antibodies against overlapping peptides spanning the entire extracellular parts of the chain. J Protein Chem. 1994 Jan; 13(1):37-47. PMID: 8011070.
      View in: PubMed
    100. Uchitel O, Engel AG, Walls TJ, Nagel A, Atassi MZ, Bril V. Congenital myasthenic syndromes: II. Syndrome attributed to abnormal interaction of acetylcholine with its receptor. Muscle Nerve. 1993 Dec; 16(12):1293-301. PMID: 8232384.
      View in: PubMed
    101. Matsui I, Sakata S, Ogawa T, Takuno H, Sarui H, Komaki T, Manshouri T, Atassi MZ. Biological activities of rat antisera raised against synthetic peptides of human thyrotropin receptor. Endocr J. 1993 Oct; 40(5):607-12. PMID: 7951527.
      View in: PubMed
    102. Atassi MZ, Manshouri T. Design of peptide enzymes (pepzymes): surface-simulation synthetic peptides that mimic the chymotrypsin and trypsin active sites exhibit the activity and specificity of the respective enzyme. Proc Natl Acad Sci U S A. 1993 Sep 1; 90(17):8282-6. PMID: 8367494; PMCID: PMC47333.
    103. Oshima M, Nakamura S, Atassi MZ. Amino acid substitutions outside a preselected antigenic region in hemoglobin affect the binding to monoclonal antibodies obtained by immunization with the synthetic region. J Protein Chem. 1993 Aug; 12(4):403-12. PMID: 8251060.
      View in: PubMed
    104. Shenoy M, David C, Oshima M, Atassi MZ, Christadoss P. Molecular immunopathogenesis of myasthenia gravis using MHC class II mutant and transgenic mice. Ann N Y Acad Sci. 1993 Jun 21; 681:329-31. PMID: 8395148.
      View in: PubMed
    105. Shenoy M, Oshima M, Atassi MZ, Christadoss P. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor. Clin Immunol Immunopathol. 1993 Mar; 66(3):230-8. PMID: 7679342.
      View in: PubMed
    106. Sakata S, Tanaka S, Okuda K, Miura K, Manshouri T, Atassi MZ. Autoimmune T-cell recognition sites of human thyrotropin receptor in Graves' disease. Mol Cell Endocrinol. 1993 Mar; 92(1):77-82. PMID: 8472870.
      View in: PubMed
    107. Abaza MS, Atassi MZ. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 145-151 (antigenic site 5) of myoglobin. J Protein Chem. 1992 Dec; 11(6):687-98. PMID: 1466763.
      View in: PubMed
    108. Ashizawa T, Ruan KH, Jinnai K, Atassi MZ. Profile of the regions on the alpha-chain of human acetylcholine receptor recognized by autoantibodies in myasthenia gravis. Mol Immunol. 1992 Dec; 29(12):1507-14. PMID: 1280762.
      View in: PubMed
    109. Abaza MS, Atassi MZ. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 113-120 (antigenic site 4) of myoglobin. J Protein Chem. 1992 Dec; 11(6):677-86. PMID: 1281636.
      View in: PubMed
    110. Abaza MS, Atassi MZ. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 94-100 (antigenic site 3) of myoglobin. J Protein Chem. 1992 Oct; 11(5):433-44. PMID: 1280436.
      View in: PubMed
    111. Abaza MS, Atassi MZ. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 56-62 (antigenic site 2) of myoglobin. J Protein Chem. 1992 Oct; 11(5):455-65. PMID: 1280438.
      View in: PubMed
    112. Abaza MS, Young CR, Atassi MZ. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 15-22 (antigenic site 1) of myoglobin. J Protein Chem. 1992 Oct; 11(5):445-54. PMID: 1280437.
      View in: PubMed
    113. Atassi MZ, Ruan KH, Jinnai K, Oshima M, Ashizawa T. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide. Proc Natl Acad Sci U S A. 1992 Jul 1; 89(13):5852-6. PMID: 1378618; PMCID: PMC49395.
    114. Atassi H, Atassi MZ. HIV envelope protein is recognized as an alloantigen by human DR-specific alloreactive T cells. Hum Immunol. 1992 May; 34(1):31-8. PMID: 1399720.
      View in: PubMed
    115. Sakata S, Ogawa T, Matsui I, Manshouri T, Atassi MZ. Biological activities of rabbit antibodies against synthetic human thyrotropin receptor peptides representing thyrotropin binding regions. Biochem Biophys Res Commun. 1992 Feb 14; 182(3):1369-75. PMID: 1540180.
      View in: PubMed
    116. Atassi MZ, Manshouri T. Synthesis of tolerogenic monomethoxypolyethylene glycol and polyvinyl alcohol conjugates of peptides. J Protein Chem. 1991 Dec; 10(6):623-7. PMID: 1726134.
      View in: PubMed
    117. Atassi MZ, Manshouri T, Sakata S. Localization and synthesis of the hormone-binding regions of the human thyrotropin receptor. Proc Natl Acad Sci U S A. 1991 May 1; 88(9):3613-7. PMID: 2023910; PMCID: PMC51502.
    118. Ruan KH, Stiles BG, Atassi MZ. The short-neurotoxin-binding regions on the alpha-chain of human and Torpedo californica acetylcholine receptors. Biochem J. 1991 Mar 15; 274 ( Pt 3):849-54. PMID: 2012611; PMCID: PMC1149988.
    119. Matsuda M, Fischer DK, Narayan RK, Atassi MZ. Preparation and characterization of antisera and of murine monoclonal antibodies to human glioma-associated antigen(s). Adv Exp Med Biol. 1991; 303:271-83. PMID: 1805572.
      View in: PubMed
    120. Fischer DK, Matsuda M, Shaban F, Narayan RK, Atassi MZ. Paucity of humoral response in patients to glioma-associated antigen(s): antigen localization by immunofluorescence. Adv Exp Med Biol. 1991; 303:263-70. PMID: 1805570.
      View in: PubMed
    121. Ashizawa T, Oshima M, Ruan KH, Atassi MZ. Autoimmune recognition profile of the alpha chain of human acetylcholine receptor in myasthenia gravis. Adv Exp Med Biol. 1991; 303:255-61. PMID: 1805569.
      View in: PubMed
    122. Fischer DK, Shaban F, Abaza MSI, Matsuda M, Narayan RK, Atassi MZ. Surgical Forum. Insufficient Patient Humoral Response to Glioma-Associated Antigen(s) Identified by Immunofluorescence, RIA, and Immunoblots Using Polyclonal and Monoclonal Reagents. 1991; 42:525–529.
    123. Atassi MZ. Reptile Venoms and Toxins in: Handbook of Natural Toxins (Tu AT, Ed.). Postsynaptic-Neurotoxin-Acetylcholine Receptor Interaction and the Binding Sites on the Two Molecules. 1991; 5:53-83.
    124. Oshima M, Ashizawa T, Pollack MS, Atassi MZ. Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the alpha subunit. Eur J Immunol. 1990 Dec; 20(12):2563-9. PMID: 2269324.
      View in: PubMed
    125. McCormick DJ, Atassi MZ. Hemoglobin binding with haptoglobin: delineation of the haptoglobin binding site on the alpha-chain of human hemoglobin. J Protein Chem. 1990 Dec; 9(6):735-42. PMID: 2073325.
      View in: PubMed
    126. Sakata S, Komaki T, Nakamura S, Ohshima M, Sagisaka K, Yoshioka N, Atassi MZ, Miura K. Binding of thyroid hormones to human hemoglobin and localization of the binding site. J Protein Chem. 1990 Dec; 9(6):743-50. PMID: 2073326.
      View in: PubMed
    127. Ruan KH, Spurlino J, Quiocho FA, Atassi MZ. Acetylcholine receptor-alpha-bungarotoxin interactions: determination of the region-to-region contacts by peptide-peptide interactions and molecular modeling of the receptor cavity. Proc Natl Acad Sci U S A. 1990 Aug; 87(16):6156-60. PMID: 2385590; PMCID: PMC54491.
    128. Smolenski LA, Kaumaya P, Atassi MZ, Pierce SK. Characteristics of peptides which compete for presented antigen-binding sites on antigen-presenting cells. Eur J Immunol. 1990 May; 20(5):953-60. PMID: 2162778.
      View in: PubMed
    129. Lewis DE, Ulrich RG, Atassi H, Atassi MZ. HLA-DR peptide inhibits HIV-induced syncytia. Immunol Lett. 1990 May; 24(2):127-31. PMID: 2191918.
      View in: PubMed
    130. Ulrich RG, Atassi MZ. Mapping of the full profile of T cell allorecognition regions on HLA-DR2 beta subunit. Eur J Immunol. 1990 Apr; 20(4):713-21. PMID: 2140786.
      View in: PubMed
    131. Nakamura S, Sakata S, Atassi MZ. Localization and synthesis of an insulin-binding region on human insulin receptor. J Protein Chem. 1990 Apr; 9(2):229-33. PMID: 2201312.
      View in: PubMed
    132. Ulrich RG, Thomas JW, Miller GG, Atassi MZ. DR beta peptides block the antigen-specific response but not the alloresponse of a dual-reactive T-cell clone. Immunol Lett. 1990 Mar-Apr; 24(1):43-7. PMID: 1695611.
      View in: PubMed
    133. Fischer DK, Shaban F, Abaza MS, Matsuda M, Narayan RK, Atassi MZ. Surgical Forum. Dissection of Human Glioma Humoral Response Using Direct Serologic, EBV-Proliferation, and Chimeric Mouse-Human Fusion Assays. 1990; 41:513-516.
    134. Oshima M, Atassi MZ. Generation of species-specific antihemoglobin antibodies by immunization with synthetic peptides of human hemoglobin. J Protein Chem. 1989 Dec; 8(6):767-78. PMID: 2624686.
      View in: PubMed
    135. Cohly HH, Morrison DR, Atassi MZ. Antigen presentation by non-immune B-cell hybridoma clones: presentation of synthetic antigenic sites reveals clones that exhibit no specificity and clones that present only one epitope. Immunol Invest. 1989 Oct; 18(8):987-92. PMID: 2479600.
      View in: PubMed
    136. Atassi MZ, Yoshioka M, Bixler GS. T cells specific for alpha-beta interface regions of hemoglobin recognize the isolated subunit but not the tetramer and indicate presentation without processing. Proc Natl Acad Sci U S A. 1989 Sep; 86(17):6729-33. PMID: 2788890; PMCID: PMC297919.
    137. Oshima M, Atassi MZ. Comparison of peptide-coating conditions in solid phase plate assays for detection of anti-peptide antibodies. Immunol Invest. 1989 Aug; 18(7):841-51. PMID: 2793210.
      View in: PubMed
    138. Ulrich RG, Atassi MZ. Alloreactive T cell recognition of the HLA-DR beta N-terminal polymorphic region. Immunol Lett. 1989 Jun 15; 21(4):285-90. PMID: 2570042.
      View in: PubMed
    139. Cohly HH, Morrison DR, Atassi MZ. Presentation of antigen to T lymphocytes by non-immune B-cell hybridoma clones: evidence for specific and non-specific presentation. Immunol Invest. 1989 Jun; 18(5):651-6. PMID: 2786844.
      View in: PubMed
    140. Atassi MZ, Bixler GS, Yokoi T. Conformation-dependent recognition of a protein by T cells requires presentation without processing. Biochem J. 1989 May 1; 259(3):731-5. PMID: 2471511; PMCID: PMC1138579.
    141. Yoshioka M, Atassi MZ. T-cell recognition and antigen presentation of myoglobin. Protein recognition by site-specific T-cell clones is influenced by amino acid substitutions outside the site. Biochem J. 1989 Mar 15; 258(3):645-51. PMID: 2786412; PMCID: PMC1138415.
    142. Pachner AR, Kantor FS, Mulac-Jericevic B, Atassi MZ. An immunodominant site of acetylcholine receptor in experimental myasthenia mapped with T lymphocyte clones and synthetic peptides. Immunol Lett. 1989 Feb; 20(3):199-204. PMID: 2469649.
      View in: PubMed
    143. Bonilla FA, Anderson RS, Atassi MZ, Bona CA. A Vh region synthetic peptide induces antibodies which bind native immunoglobulins and augment an immune response to antigen. Adv Exp Med Biol. 1989; 251:129-43. PMID: 2481956.
      View in: PubMed
    144. Atassi MZ, Torres JV, Wyde PR. Cytotoxic and helper T-lymphocyte responses to antibody recognition regions on influenza virus hemagglutinin. Adv Exp Med Biol. 1989; 251:49-63. PMID: 2532857.
      View in: PubMed
    145. Atassi MZ, Atassi H. Proceedings of the XIVth Congress of the European Academy of Allergy and Clinical Immunology. Antibody and T-Lymphocyte Recognition Regions on Ragweed Allergen Amb a III (Ra3). 1989; 33-40.
    146. Fischer DK, Narayan RK, Abaza MS, Matsuda M, Atassi MZ . Surgical Forum. Epstein-Barr Virus-Immortalized Peripheral Blood Lymphocytes from Astrocytoma Patients Contain Supernatant Antibodies Highly Reactive with Glioma Antigens. 1989; 40:501-504.
    147. Atassi MZ. Recognition sites of hemoglobin and the preparation of antibodies with preselected specificity for clinical diagnosis and forensic medicine. Nihon Hoigaku Zasshi. 1988 Dec; 42(6):469-75. PMID: 3073239.
      View in: PubMed
    148. Atassi MZ, McDaniel CS, Manshouri T. Mapping by synthetic peptides of the binding sites for acetylcholine receptor on alpha-bungarotoxin. J Protein Chem. 1988 Oct; 7(5):655-66. PMID: 3255383.
      View in: PubMed
    149. Torres JV, Wyde PR, Atassi MZ. Cytotoxic T lymphocyte recognition sites on influenza virus hemagglutinin. Immunol Lett. 1988 Sep; 19(1):49-53. PMID: 3263948.
      View in: PubMed
    150. Gorai I, Aihara M, Bixler GS, Atassi MZ, Walden P, Klein J. T cell response to myoglobin: a comparison of T cell clones in high-responder and low-responder mice. Eur J Immunol. 1988 Sep; 18(9):1329-35. PMID: 2458940.
      View in: PubMed
    151. Cohly HH, Morrison DR, Atassi MZ. Presentation of antigen to T lymphocytes by non-immune B-cell hybridoma clones: evidence for specific and non-specific presentation. Immunol Invest. 1988 Aug-Oct; 17(6-7):615-20. PMID: 3266192.
      View in: PubMed
    152. Cohly HH, Morrison DR, Atassi MZ. Conformation-dependent recognition of a protein by T-lymphocytes: apomyoglobin-specific T-cell clone recognizes conformational changes between apomyoglobin and myoglobin. Immunol Invest. 1988 Jun; 17(4):337-42. PMID: 3263321.
      View in: PubMed
    153. Sakata S, Kobayashi M, Miura K, Atassi MZ. Molecular recognition of human insulin receptor by autoantibodies in a human serum. Immunol Invest. 1988 May; 17(3):237-42. PMID: 3410514.
      View in: PubMed
    154. Mulac-Jericevic B, Manshouri T, Yokoi T, Atassi MZ. The regions of alpha-neurotoxin binding on the extracellular part of the alpha-subunit of human acetylcholine receptor. J Protein Chem. 1988 Apr; 7(2):173-7. PMID: 3255368.
      View in: PubMed
    155. Atassi MZ, Manshouri T, Yokoi T. Recognition of inter-transmembrane regions of acetylcholine receptor alpha subunit by antibodies, T cells and neurotoxins. Implications for membrane-subunit organization. FEBS Lett. 1988 Feb 15; 228(2):295-300. PMID: 3257740.
      View in: PubMed
    156. Atassi MZ. Modern Methods in Protein Chemistry. Strategies for the Localization and Synthesis of Protein Binding Sites. 1988; 3:1-40.
    157. Atassi MZ, Bixler GS, Jr. Vaccines: New Concepts and Developments (Edited by Kohler H, LoVerde PT). Comparison of the Submolecular Recognition of Proteins by T and B Cells. 1988; 58–70.
    158. Sakata S, Nakamura S, Yoshioka N, Atassi MZ, Miura K. The Thyroid (Edited by S. Nagataki S, Torizuka K). Thyroid Hormone Binding to Hemoglobin. 1988; 375–378.
    159. Mulac-Jericevic B, Atassi MZ. Profile of the alpha-bungarotoxin-binding regions on the extracellular part of the alpha-chain of Torpedo californica acetylcholine receptor. Biochem J. 1987 Dec 15; 248(3):847-52. PMID: 3435488; PMCID: PMC1148626.
    160. Yokoi T, Mulac-Jericevi? B, Kurisaki J, Atassi MZ. T lymphocyte recognition of acetylcholine receptor: localization of the full T cell recognition profile on the extracellular part of the alpha chain of Torpedo californica acetylcholine receptor. Eur J Immunol. 1987 Dec; 17(12):1697-702. PMID: 2446878.
      View in: PubMed
    161. Torres JV, Yoshioka N, Atassi MZ. Antigenic regions on the beta chain of human chorionic gonadotropin and development of hormone specific antibodies. Immunol Invest. 1987 Nov; 16(7):607-18. PMID: 2450842.
      View in: PubMed
    162. McDaniel C Steve, Manshouri Taghi, and Atassi M. Zouhair. Novel Peptide Mimicking the Interaction of a-Neurotoxins with Acetylcholine Receptor. Journal of Protein Chemistry. 1987; 6(5):455-461.
    163. Marks DH, Brown DR, Ottinger WE, Atassi MZ. Antibody response to transfusion with pyridoxalated polymerized hemoglobin solution. Mil Med. 1987 Sep; 152(9):473-7. PMID: 3118250.
      View in: PubMed
    164. Atassi MZ, Yoshioka M, Bean M, Bixler GS. Non-specific peptide size effects in the recognition by site-specific T-cell clones. Demonstration with a T site of myoglobin. Biochem J. 1987 Sep 1; 246(2):307-12. PMID: 3500708; PMCID: PMC1148277.
    165. Mulac-Jericevi? B, Kurisaki J, Atassi MZ. Profile of the continuous antigenic regions on the extracellular part of the alpha chain of an acetylcholine receptor. Proc Natl Acad Sci U S A. 1987 Jun; 84(11):3633-7. PMID: 2438685; PMCID: PMC304929.
    166. Atassi H, Ulrich RG, Atassi MZ. The continuous antigenic regions in the second domain of the beta chain of human MHC DR2 antigen: antigenic profile of the entire extracellular part of the chain. Eur J Immunol. 1987 Jun; 17(6):769-73. PMID: 2439349.
      View in: PubMed
    167. Atassi MZ, Mulac-Jericevic B, Yokoi T, Manshouri T. Localization of the functional sites on the alpha chain of acetylcholine receptor. Fed Proc. 1987 Jun; 46(8):2538-47. PMID: 2439384.
      View in: PubMed
    168. Ulrich RG, Atassi H, Lutz P, Cresswell P, Atassi MZ. Immune recognition of human major histocompatibility antigens: localization by a comprehensive synthetic strategy of the continuous antigenic sites in the first domain of HLA-DR2 beta chain. Eur J Immunol. 1987 Apr; 17(4):497-502. PMID: 2436923.
      View in: PubMed
    169. Bixler GS, Atassi MZ. T-cell recognition and antigen presentation of lysozyme. Adv Exp Med Biol. 1987; 225:89-101. PMID: 3502593.
      View in: PubMed
    170. Atassi MZ, Bixler GS. T-cell recognition and antigen presentation of myoglobin. Adv Exp Med Biol. 1987; 225:65-87. PMID: 3331065.
      View in: PubMed
    171. Yokoi T, Mulac-Jericevic B, Atassi MZ. The regions of T-cell recognition on the extracellular part of the alpha chain of Torpedo californica acetylcholine receptor. Adv Exp Med Biol. 1987; 225:103-13. PMID: 3502590.
      View in: PubMed
    172. Bixler GS, Jr, Atassi MZ. Synthetic Vaccines (Edited by Arnon R). B-Cell Recognition of Protein Antigens: Perspectives From the Submolecular Level. 1987; 1:39–71.
    173. Atassi MZ, Bixler GS Jr. Antigen-Specific T Cell Receptors and Factors, Ed. Marchalonis. A Comparison of T-Cell and B-Cell Recognition of Defined Protein Antigens. 1987; 1:7–63.
    174. Atassi MZ, Atassi H, Ulrich RG. H-2 Antigens. Genes, Molecules, Function, NATO ASI Series, Series A. David CS Editor. Immune Recognition of Human MHC DR2 Antigen. 1987; 144:837-845.
    175. Bixler GS, Bean M, Atassi MZ. Site recognition by protein-primed T cells shows a non-specific peptide size requirement beyond the essential residues of the site. Demonstration by defining an immunodominant T site in myoglobin. Biochem J. 1986 Nov 15; 240(1):139-46. PMID: 2435278; PMCID: PMC1147386.
    176. Sakata S, Yoshioka N, Atassi MZ. Human haptoglobin binds to human myoglobin. Biochim Biophys Acta. 1986 Sep 26; 873(2):312-5. PMID: 3756181.
      View in: PubMed
    177. Mulac-Jericevic B, Atassi MZ. Segment alpha 182-198 of Torpedo californica acetylcholine receptor contains second toxin-binding region and binds anti-receptor antibodies. FEBS Lett. 1986 Apr 7; 199(1):68-74. PMID: 3956748.
      View in: PubMed
    178. Yoshioka N, Atassi MZ. Haemoglobin binding with haptoglobin. Localization of the haptoglobin-binding sites on the beta-chain of human haemoglobin by synthetic overlapping peptides encompassing the entire chain. Biochem J. 1986 Mar 1; 234(2):453-6. PMID: 3718478; PMCID: PMC1146586.
    179. Yoshioka N, Atassi MZ. Subunit interacting surfaces of human haemoglobin. Localization of the alpha-subunit-beta-subunit interacting surfaces on the beta-chain by a comprehensive synthetic strategy. Biochem J. 1986 Mar 1; 234(2):457-61. PMID: 3718479; PMCID: PMC1146587.
    180. Yoshioka M, Yoshioka N, Atassi MZ. T-cell recognition of human haemoglobin. Localization of the full T-cell recognition profile of the beta-chain by a comprehensive synthetic strategy. Biochem J. 1986 Mar 1; 234(2):449-52. PMID: 3487315; PMCID: PMC1146585.
    181. Kurisaki J, Atassi H, Atassi MZ. T cell recognition of ragweed allergen Ra3: localization of the full T cell recognition profile by synthetic overlapping peptides representing the entire protein chain. Eur J Immunol. 1986 Mar; 16(3):236-40. PMID: 2420609.
      View in: PubMed
    182. Atassi H, Atassi MZ. Antibody recognition of ragweed allergen Ra3: localization of the full profile of the continuous antigenic sites by synthetic overlapping peptides representing the entire protein chain. Eur J Immunol. 1986 Mar; 16(3):229-35. PMID: 2420608.
      View in: PubMed
    183. Yoshioka N, Atassi MZ. Antigenic structure of human haemoglobin. Localization of the antigenic sites of the beta-chain in three host species by synthetic overlapping peptides representing the entire chain. Biochem J. 1986 Mar 1; 234(2):441-7. PMID: 2424430; PMCID: PMC1146584.
    184. Atassi MZ. Preparation of monoclonal antibodies to preselected protein regions. Methods Enzymol. 1986; 121:69-95. PMID: 2425217.
      View in: PubMed
    185. Atassi MZ, Pelley RP. Medical Microbiology (Edited by Baron S). Antigen-Antibody Reactions and Their Biologic Consequences. 1986; 46–61.
    186. Bixler GS, Jr, Atassi MZ. Protides of the Biological Fluids (Edited by Peeters H). Localization of the Continuous Sites Stimulating T-Cell Proliferation and the Definition of an Immunodominant Region In Myoglobin. 1986; 34:165–168.
    187. Atassi MZ. Protein Engineering (Edited by Inouye M, Sarma R). Surface-Simulation Synthesis and Its Application in Protein Molecular Recognition. 1986; 125–153.
    188. Atassi MZ, Kurisaki J-I. Protides of the Biological Fluids (Edited by Peeters H). Synthetic Localization of T- and B-Cell Recognition Sites of Influenza A Virus Hemagglutinin and the Antibody and T-Cell Responses to the Sites. 1986; 34:157–160.
    189. Lennon VA, McCormick DJ, Lambert EH, Griesmann GE, Atassi MZ. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies. Proc Natl Acad Sci U S A. 1985 Dec; 82(24):8805-9. PMID: 3878521; PMCID: PMC391526.
    190. McCormick DJ, Lennon VA, Atassi MZ. Antigenicity of synthetic peptides 159-169 and 151-169 of Torpedo acetylcholine receptor alpha chain. Biochem J. 1985 Oct 1; 231(1):245-6. PMID: 4062890; PMCID: PMC1152736.
    191. Bixler GS, Atassi MZ. Antigen presentation of myoglobin: profiles of T cell proliferative responses following priming with synthetic overlapping peptides encompassing the entire molecule. Eur J Immunol. 1985 Sep; 15(9):917-22. PMID: 3876224.
      View in: PubMed
    192. Bixler GS, Yoshida T, Atassi MZ. Antigen presentation of lysozyme: T-cell recognition of peptide and intact protein after priming with synthetic overlapping peptides comprising the entire protein chain. Immunology. 1985 Sep; 56(1):103-12. PMID: 3876269; PMCID: PMC1453666.
    193. Atassi H, Atassi MZ. Localization of the continuous allergenic sites of ragweed allergen Ra3 by a comprehensive synthetic strategy. FEBS Lett. 1985 Aug 19; 188(1):96-100. PMID: 2410296.
      View in: PubMed
    194. Atassi MZ. Surface-simulation synthesis of the substrate-binding site of an enzyme. Demonstration with trypsin. Biochem J. 1985 Mar 1; 226(2):477-85. PMID: 3994669; PMCID: PMC1144735.
    195. McCormick DJ, Lennon VA, Atassi MZ. Synthesis of an antigenic site of native acetylcholine receptor peptide 159-169 of Torpedo acetylcholine receptor alpha-chain. Biochem J. 1985 Feb 15; 226(1):193-7. PMID: 2579640; PMCID: PMC1144692.
    196. Young CR, Atassi MZ. T-cell dependency of the antibody response to free small synthetic peptides of a protein: demonstration with an antigenic site of myoglobin. Immunol Invest. 1985 Feb; 14(1):1-5. PMID: 2581894.
      View in: PubMed
    197. Atassi MZ, Young CR. Discovery and implications of the immunogenicity of free small synthetic peptides: powerful tools for manipulating the immune system and for production of antibodies and T cells of preselected submolecular specificities. Crit Rev Immunol. 1985; 5(4):387-409. PMID: 3899514.
      View in: PubMed
    198. Atassi MZ. Perspectives of the immunology of proteins. Adv Exp Med Biol. 1985; 185:1-25. PMID: 2416195.
      View in: PubMed
    199. McCormick DJ, Atassi MZ. Localization and synthesis of the acetylcholine-binding site in the alpha-chain of the Torpedo californica acetylcholine receptor. Biochem J. 1984 Dec 15; 224(3):995-1000. PMID: 6525183; PMCID: PMC1144538.
    200. Atassi MZ. Antigenic structures of proteins. Their determination has revealed important aspects of immune recognition and generated strategies for synthetic mimicking of protein binding sites. Eur J Biochem. 1984 Nov 15; 145(1):1-20. PMID: 6208027.
      View in: PubMed
    201. Bixler GS, Yoshida T, Atassi MZ. T cell recognition of lysozyme. IV. Localization and genetic control of the continuous T cell recognition sites by synthetic overlapping peptides representing the entire protein chain. J Immunogenet. 1984 Oct-Dec; 11(5-6):327-37. PMID: 6085692.
      View in: PubMed
    202. Bixler GS, Atassi MZ. T cell recognition of myoglobin. Localization of the sites stimulating T cell proliferative responses by synthetic overlapping peptides encompassing the entire molecule. J Immunogenet. 1984 Oct-Dec; 11(5-6):339-53. PMID: 6085693.
      View in: PubMed
    203. Bixler GS, Atassi MZ. T cell recognition of lysozyme. III. Recognition of the 'surface-simulation' synthetic antigenic sites. J Immunogenet. 1984 Jun-Aug; 11(3-4):245-50. PMID: 6335154.
      View in: PubMed
    204. Krco CJ, Abramson EJ, Yoshoka N, Atassi MZ, David CS. Genetic control of the immune response to haemoglobin. V. Production and characterization of A beta restricted T cell lines and clones. J Immunogenet. 1984 Feb; 11(1):33-43. PMID: 6423733.
      View in: PubMed
    205. Bixler GS, Yoshida T, Atassi MZ. T-cell recognition of lysozyme. I. Localization of regions stimulating T-cell proliferative response by synthetic overlapping peptides encompassing the entire molecule. Exp Clin Immunogenet. 1984; 1(2):99-111. PMID: 6400996.
      View in: PubMed
    206. Atassi MZ, Kurisaki J. A novel approach for localization of the continuous protein antigenic sites by comprehensive synthetic surface scanning: antibody and T-cell activity to several influenza hemagglutinin synthetic sites. Immunol Commun. 1984; 13(6):539-51. PMID: 6085322.
      View in: PubMed
    207. Bixler GS, Yoshida T, Atassi MZ. T cell recognition of lysozyme. II. Shift in specificity during long-term culture determined by synthetic overlapping peptides comprising the entire protein chain. Immunol Commun. 1984; 13(2):161-72. PMID: 6204928.
      View in: PubMed
    208. Atassi MZ. Molecular Immunology (Edited by Atassi MZ, van Oss CJ, Absolom DR). Immune Recognition of Proteins. 1984; 15–51.
    209. Atassi MZ. Conformationally Directed Drug Design" (Edited by Vida JA, Gordon M). Localization and Synthesis of Protein Antigenic Sites. Use of Free Synthetic Peptides for the Preparation of Antibodies and T-Cells of Preselected Specificities. 1984; 251:29–71.
    210. Atassi MZ. Proceedings of the Fourth Annual Chemical Defense Bioscience Review, US Army Medical Research Institute of Chemical Defense. Design and Synthesis of Peptides mimicking the Active Site of a Serine Esterase with Covalent Binding to Organophosphorus Inhibitors. 1984; 335-368.
    211. Young CR, Schmitz HE, Atassi MZ. Genetic control of the immune response to myoglobin. XVI. Control of antibodies with preselected specificities following immunization with free synthetic peptides representing the antigenic sites or surface non-immunogenic locations in the protein. J Immunogenet. 1983 Dec; 10(6):453-64. PMID: 6198400.
      View in: PubMed
    212. Yoshioka M, Bixler GS, Atassi MZ. Preparation of T-lymphocyte lines and clones with specificities to preselected protein sites by in vitro passage with free synthetic peptides: demonstration with myoglobin sites. Mol Immunol. 1983 Oct; 20(10):1133-7. PMID: 6609306.
      View in: PubMed
    213. Schmitz HE, Atassi H, Atassi MZ. Production of monoclonal antibodies with preselected submolecular binding specificities to protein antigenic sites: antibodies to sperm whale myoglobin sites. Mol Immunol. 1983 Jul; 20(7):719-26. PMID: 6193418.
      View in: PubMed
    214. Young DR, Schmitz HE, Atassi MZ. Antibodies with specificities to preselected protein regions evoked by free synthetic peptides representing protein antigenic sites or other surface locations: demonstration with myoglobin. Mol Immunol. 1983 May; 20(5):567-70. PMID: 6192328.
      View in: PubMed
    215. Young CR, Atassi MZ. T-lymphocyte recognition of sperm-whale myoglobin. Specificity of T-cell recognition following neonatal tolerance with either myoglobin or synthetic peptides of an antigenic site. J Immunogenet. 1983 Apr; 10(2):161-9. PMID: 6189919.
      View in: PubMed
    216. Young CR, Atassi MZ. T-lymphocyte recognition of sperm-whale myoglobin. Responses of T-cells from mouse strains primed with synthetic peptide carrying antigenic site 5 and relation to antigen presentation. J Immunogenet. 1983 Apr; 10(2):151-60. PMID: 6189918.
      View in: PubMed
    217. Young CR, Atassi MZ. T-lymphocyte recognition of sperm-whale myoglobin. Recognition of synthetic peptides carrying antigenic site 5 by myoglobin-primed T-cells. J Immunogenet. 1983 Apr; 10(2):139-49. PMID: 6189917.
      View in: PubMed
    218. Atassi MZ, Webster RG. Localization, synthesis, and activity of an antigenic site on influenza virus hemagglutinin. Proc Natl Acad Sci U S A. 1983 Feb; 80(3):840-4. PMID: 6187004; PMCID: PMC393476.
    219. Bixler GS, Atassi MZ. Molecular localization of the full profile of the continuous regions recognized by myoglobin-primed T-cells using synthetic overlapping peptides encompassing the entire molecule. Immunol Commun. 1983; 12(6):593-603. PMID: 6201435.
      View in: PubMed
    220. Schmitz HE, Atassi H, Atassi MZ. Production of monoclonal antibodies to surface regions that are non-immunogenic in a protein using free synthetic peptide as immunogens: demonstration with sperm-whale myoglobin. Immunol Commun. 1983; 12(2):161-75. PMID: 6192078.
      View in: PubMed
    221. Young CR, Schmitz HE, Atassi MZ. Antibodies with preselected specificities to protein regions evoked by immunization with free synthetic peptides: dose response to myoglobin antigenic sites reveal an optimum dose for each antigenic site. Immunol Commun. 1983; 12(4):419-28. PMID: 6195093.
      View in: PubMed
    222. Schmitz HE, Atassi H, Atassi MZ. Production of monoclonal antibodies with pre-selected submolecular binding specificities to protein determinants: demonstration with sperm whale myoglobin. Mol Immunol. 1982 Dec; 19(12):1699-1702. PMID: 6186911.
      View in: PubMed
    223. Atassi MZ, Sakata S, Sakata S. Immune recognition of serum albumin. XVI. Role of adjuvant in the autoimmune response to mouse serum albumin. Mol Immunol. 1982 Nov; 19(11):1509-12. PMID: 7183914.
      View in: PubMed
    224. Young CR, Atassi MZ. Genetic control of the immune response to myoglobin. IX. Overcoming genetic control of antibody response to antigenic sites by increasing the dose of antigen used in immunization. J Immunogenet. 1982 Oct; 9(5):343-51. PMID: 6184418.
      View in: PubMed
    225. Atassi MZ. Immune recognition of serum albumin.15. Localization by synthesis of antigenic site 4 of bovine serum albumin to the region around the disulfide bond 166-175. Biochim Biophys Acta. 1982 Jun 24; 704(3):552-5. PMID: 6180768.
      View in: PubMed
    226. Krco CJ, Kazim AL, Atassi MZ, David CS. Genetic control of the immune response to haemoglobin. IV. Ly-1+ T-cells and appropriate non-H-2 genes are required for in vitro responses to alpha- and beta-subunits of human adult haemoglobin. J Immunogenet. 1982 Apr; 9(2):93-100. PMID: 6806395.
      View in: PubMed
    227. Kazim AL, Atassi MZ. Structurally inherent antigenic sites. Localization of the antigenic sites of the alpha-chain of human haemoglobin in three host species by a comprehensive synthetic approach. Biochem J. 1982 Apr 1; 203(1):201-8. PMID: 6179509; PMCID: PMC1158211.
    228. Atassi MZ, Sakata S. Binding with lysozyme of antibodies against surface-simulation peptides representing the lysozyme antigenic sites. Biochem J. 1982 Mar 1; 201(3):669-72. PMID: 7092817; PMCID: PMC1163698.
    229. Atassi MZ, Long PM, Beisel K, Sakata S, Peters T, David CS. Immune recognition of serum albumin--XIV. Cross-reactivity by T-lymphocyte proliferation of subdomains 3, 6 and 9 of bovine serum albumin. Mol Immunol. 1982 Feb; 19(2):313-21. PMID: 6178957.
      View in: PubMed
    230. Krco CJ, Kazim AL, Atassi MZ, David CS. Genetic control of the immune response to hemoglobin and its subunits. Adv Exp Med Biol. 1982; 150:127-40. PMID: 6183940.
      View in: PubMed
    231. Infante AJ, Atassi MZ, Fathman CG. Myoglobin-reactive T cell clones. Adv Exp Med Biol. 1982; 150:159-82. PMID: 6183942.
      View in: PubMed
    232. David CS, Atassi MZ. Genetic control and intersite influences on the immune response to sperm whale myoglobin. Adv Exp Med Biol. 1982; 150:97-125. PMID: 6183948.
      View in: PubMed
    233. Young CR, Atassi MZ. Antibodies to sperm-whale myoglobin evoked by free synthetic peptides of an antigenic site. Immunol Commun. 1982; 11(1):9-16. PMID: 6178684.
      View in: PubMed
    234. Young CR, Atassi MZ. Dissection of the molecular parameters for T-cell recognition of a myoglobin antigenic site. Adv Exp Med Biol. 1982; 150:73-93. PMID: 6183947.
      View in: PubMed
    235. Krco CJ, Kazim AL, Atassi MZ, Melvold R, David CS. Genetic control of the immune response to haemoglobin. III. Variant A beta (bm12) but not Ae (D2.GD) Ia polypeptides alter immune responsiveness towards the alpha -subunit of human haemoglobin. J Immunogenet. 1981 Dec; 8(6):471-6. PMID: 6801143.
      View in: PubMed
    236. Sakata S, Atassi MZ. Immune recognition of serum albumin--XIII. Autoreactivity with rabbit serum albumin of rabbit antibodies against bovine or human serum albumins and autoimmune recognition of rabbit serum albumin. Mol Immunol. 1981 Nov; 18(11):961-7. PMID: 6176849.
      View in: PubMed
    237. Infante AJ, Atassi MZ, Fathman CG. T cell clones reactive with sperm whale myoglobin. Isolation of clones with specificity for individual determinants on myoglobin. J Exp Med. 1981 Nov 1; 154(5):1342-56. PMID: 6170716; PMCID: PMC2186505.
    238. Atassi MZ. Immune recognition of cytochrome C. I. Investigation by synthesis whether antigenic sites of polymeric cytochrome coincide with locations of sequence differences between the immunizing and host cytochromes. Mol Immunol. 1981 Nov; 18(11):1021-5. PMID: 6176848.
      View in: PubMed
    239. Chang JY, Gleich GJ, Atassi MZ. The role of the thiol group and the disulfide bond in the conformation and the IgE and IgG binding activities of ragweed allergen Ra3. Mol Immunol. 1981 Nov; 18(11):991-7. PMID: 6176852.
      View in: PubMed
    240. Atassi MZ, Yokota S, Twining SS, Lehmann H, David CS. Genetic control of the immune response to myoglobin. VI. Inter-site influences in T-lymphocyte proliferative response from analysis of cross-reactions of ten myoglobins in terms of substitutions in the antigenic sites and in environmental residues of the sites. Mol Immunol. 1981 Oct; 18(10):945-8. PMID: 6977699.
      View in: PubMed
    241. Young CR, Connor GP, Atassi MZ. Genetic control of the immune response to myoglobin. VIII. Control of antibody affinity. J Immunogenet. 1981 Oct; 8(5):387-94. PMID: 6795280.
      View in: PubMed
    242. Krco CJ, Kazim AL, Atassi MZ, David CS. Genetic control of the immune response to haemoglobin. II. Studies using purified alpha-chain and beta-chain as immunogens. J Immunogenet. 1981 Oct; 8(5):395-403. PMID: 6795281.
      View in: PubMed
    243. Atassi MZ, Kazim AL, Sakata S. High yield coupling of peptides to protein carriers. Biochim Biophys Acta. 1981 Sep 29; 670(2):300-2. PMID: 7295778.
      View in: PubMed
    244. Krco J, Kazim AL, Atassi MZ, David CS. Genetic control of the immune response to haemoglobin. I. Demonstration of separate genetic control of the responses to the alpha- and beta-subunits by in vitro lymphocyte proliferation. J Immunogenet. 1981 Aug; 8(4):315-22. PMID: 6792290.
      View in: PubMed
    245. Kazim AL, Atassi MZ. Haemoglobin binding with haptoglobin. Localization of the haptoglobin-binding site on the alpha-chain of human haemoglobin. Biochem J. 1981 Aug 1; 197(2):507-10. PMID: 7325968; PMCID: PMC1163152.
    246. Sakata S, Reed RG, Peters T, Atassi MZ. Immune recognition of serum albumin--XII. Evidence for time-dependent immunochemical cross-reactivity of subdomains 3, 6 and 9 of bovine serum albumin by quantitative immunoadsorbent titration studies. Mol Immunol. 1981 Jun; 18(6):553-60. PMID: 6171723.
      View in: PubMed
    247. Twining SS, Lehmann H, Atassi MZ. Time-dependent study of the antibody response to sperm-whale myoglobin: recognition of the antigenic sites is unaltered over an extended period of immunization. Mol Immunol. 1981 Jun; 18(6):473-9. PMID: 6171719.
      View in: PubMed
    248. Twining SS, David CS, Atassi MZ. Genetic control of the immune response to myoglobin. IV. Mouse antibodies in outbred and congenic strains against sperm-whale myoglobin recognize the same antigenic sites that are recognized by antibodies raised in other species. Mol Immunol. 1981 May; 18(5):447-50. PMID: 6171717.
      View in: PubMed
    249. Young CR, O'Connor GP, Atassi MZ. Genetic control of the immune response to myoglobin. VII. Antibody responses to myoglobin variants reveal that gene restriction of the antibody responses to myoglobin antigenic sites is dependent on the chemical properties of the sites. Immunol Commun. 1981; 10(6):483-98. PMID: 6797932.
      View in: PubMed
    250. Atassi MZ, Twining SS, Lehmann H, David CS. Genetic control of the immune response to myoglobin. V. Analysis of the cross-reactivity of 12 myoglobins with sperm-whale myoglobin antisera of inbred mouse strains in terms of substitutions in the antigenic sites and in the environmental residues of the sites. Immunol Commun. 1981; 10(4-5):359-65. PMID: 7333635.
      View in: PubMed
    251. Kazim AL, Atassi MZ. Nearest-neighbour analysis of myoglobin antigenic sites. Nearest-neighbour residues whose replacement can alter the environment of binding-site residue(s) and thus change their characteristics and binding capability. Biochem J. 1980 Dec 1; 191(3):673-80. PMID: 6169337; PMCID: PMC1162268.
    252. Twining SS, Lehmann H, Atassi MZ. The antibody response to myoglobin is independent of the immunized species. Analysis in terms of replacements in the antigenic sites and in environmental residues of the cross-reactions of fifteen myoglobins with sperm-whale myoglobin antisera raised in different species. Biochem J. 1980 Dec 1; 191(3):681-97. PMID: 6169338; PMCID: PMC1162269.
    253. Kazim AL, Atassi MZ. A novel and comprehensive synthetic approach for the elucidation of protein antigenic structures. Determination of the full antigenic profile of the alpha-chain of human haemoglobin. Biochem J. 1980 Oct 1; 191(1):261-4. PMID: 6162459; PMCID: PMC1162207.
    254. Sakata S, Atassi MZ. Immune recognition of serum albumin. 11. Mouse antibodies against bovine serum albumin recognize the same antigenic sites that are recognized by rabbit antibodies. Biochim Biophys Acta. 1980 Sep 23; 625(1):159-62. PMID: 7417497.
      View in: PubMed
    255. Atassi MZ. Precise determination of protein antigenic structures has unravelled the molecular immune recognition of proteins and provided a prototype for synthetic mimicking of other protein binding sites. Mol Cell Biochem. 1980 Aug 29; 32(1):21-43. PMID: 6160381.
      View in: PubMed
    256. Atassi MZ, Sakata S. Antibodies to synthetic antibody-combining sites. Antibodies against a surface-simulation peptide with antibody-combining activity toward lysozyme antigenic site 3 react with lysozyme antibodies. Biochim Biophys Acta. 1980 Aug 21; 624(2):573-8. PMID: 6158339.
      View in: PubMed
    257. Yokota S, David CS, Atassi MZ. Genetic control of the immune response to myoglobin. 3. Autoimmune T-lymphocyte proliferative response to mouse myoglobin. Mol Immunol. 1980 Aug; 17(8):1079-82. PMID: 6777665.
      View in: PubMed
    258. Kazim AL, Atassi MZ. Antibody combining sites can be mimicked synthetically. Surface-simulation synthesis of the phosphorylcholine-combining site of myeloma protein M-603. Biochem J. 1980 Jun 1; 187(3):661-6. PMID: 6204636; PMCID: PMC1162449.
    259. Atassi MZ, Kazim AL. Distance calculation of residues neighbouring to lysozyme antigenic sites. Site-neighbouring residues whose evolutionary substitution can modify the characteristics and binding energy of the sites. Biochem J. 1980 Apr 1; 187(1):163-72. PMID: 6157386; PMCID: PMC1162504.
    260. Paull BR, Gleich GJ, Atassi MZ. Structure and activity of ragweed antigen E--III. The role of the thiol group in the conformation and allergenic activity of antigen E. Mol Immunol. 1980 Feb; 17(2):281-6. PMID: 7393233.
      View in: PubMed
    261. Atassi MZ. Structure and Variation in Influenza Virus (Edited by Laver WG and Air G). Molecular Immune Recognition of Proteins: The Precise Determination or Protein Antigenic Sites has Led to Synthesis of Antibody Combining Sites and Other Types of Protein Binding Sites. 1980; 241-272.
    262. Sakata S, Atassi MZ. Immunochemistry of serum albumin. X. Five major antigenic sites of human serum albumin are extrapolated from bovine albumin and confirmed by synthetic peptides. Mol Immunol. 1980 Jan; 17(1):139-42. PMID: 6153752.
      View in: PubMed
    263. Kazim AL, Atassi MZ. Haemoglobin binding with haptoglobin. Unequivocal demonstration that the beta-chains of human haemoglobin bind to haptoglobin. Biochem J. 1980 Jan 1; 185(1):285-7. PMID: 7378053; PMCID: PMC1161299.
    264. Okuda K, Sakata S, Atassi MZ, David CS. Genetic control of the immune response to hen's egg-white lysozyme in mice. I. Antibody and T-lymphocyte proliferative responses to the native protein. J Immunogenet. 1979 Dec; 6(6):447-52. PMID: 118223.
      View in: PubMed
    265. Paull BR, Gleich GJ, Atassi MZ. Structure and activity of ragweed antigen E. II. Allergenic crossreactivity of the subunits. J Allergy Clin Immunol. 1979 Dec; 64(6 Pt 1):539-45. PMID: 92489.
      View in: PubMed
    266. Gooch GT, Stavitsky AB, Harold WW, Manderino G, Atassi MZ. Evidence for cellular but not serologic cross-reactivity between keyhole limpet hemocyanin and sperm-whale myoglobin. Cell Immunol. 1979 Sep 1; 46(2):384-97. PMID: 314851.
      View in: PubMed
    267. Sakata S, Reed RG, Peters T, Atassi MZ. Immunochemistry of serum albumin--VIII. The antigenic reactivity of the third domain of bovine serum albumin resides in the last sub-domain. A dynamic examination of the change of antibody affinity and specificity. Mol Immunol. 1979 Sep; 16(9):703-9. PMID: 43473.
      View in: PubMed
    268. Kazim AL, Habeeb AF, Atassi MZ. Immunochemistry of serum albumin--VII. Effects of chemical modification of tyrosine and arginine residues on the conformation and immunochemistry of a fragment corresponding to the last third of bovine serum albumin. Mol Immunol. 1979 Jul; 16(7):457-64. PMID: 500110.
      View in: PubMed
    269. Okuda K, Twining SS, David CS, Atassi MZ. Genetic control of immune response to sperm whale myoglobin in mice. II. T lymphocyte proliferative response to the synthetic antigenic sites. J Immunol. 1979 Jul; 123(1):182-8. PMID: 312873.
      View in: PubMed
    270. Sakata S, Atassi MZ. Immunochemistry of serum albumin--V. A time-dependent examination of the antibody response to bovine serum albumin by the activity of its third domain. Mol Immunol. 1979 Jul; 16(7):451-6. PMID: 500109.
      View in: PubMed
    271. Stavitsky AB, Atassi MZ, Gooch GT, Harold WW. Synthetic myoglobin peptides inhibit spontaneous anamnestic antibody responses by myoglobin-primed rabbit lymph node cells. Cell Immunol. 1979 Jun; 45(1):195-8. PMID: 455484.
      View in: PubMed
    272. Atassi MZ, Sakata S, Kazim AL. Localization and verification by synthesis of five antigenic sites of bovine serum albumin. Biochem J. 1979 May 1; 179(2):327-31. PMID: 486084; PMCID: PMC1186630.
    273. Sakata S, Atassi MZ. Immunochemistry of serum albumin. VI. A dynamic approach to the immunochemical cross reactions of proteins using serum albumins from various species as models. Biochim Biophys Acta. 1979 Feb 26; 576(2):322-32. PMID: 427191.
      View in: PubMed
    274. Atassi MZ. The antigenic structure of myoglobin and initial consequences of its precise determination. CRC Crit Rev Biochem. 1979; 6(4):337-69. PMID: 88297.
      View in: PubMed
    275. Atassi MZ. Determination of the entire antigenic structure of native lysozyme by surface-simulation synthesis, a novel concept in molecular recognition. CRC Crit Rev Biochem. 1979; 6(4):371-400. PMID: 88298.
      View in: PubMed
    276. Twining SS, Atassi MZ. Use of immunoadsorbents for the study of antibody binding to sperm whale myoglobin and its synthetic antigenic sites. J Immunol Methods. 1979; 30(2):139-51. PMID: 91647.
      View in: PubMed
    277. Atassi MZ. Precise determination of the entire antigenic structure of lysozyme: molecular features of protein antigenic structures and potential of "surface-simulation" synthesis--a powerful new concept for protein binding sites. Immunochemistry. 1978 Dec; 15(12):909-36. PMID: 86497.
      View in: PubMed
    278. Okuda K, Christadoss PR, Twining S, Atassi MZ, David CS. Genetic control of immune response to sperm whale myoglobin in mice. I. T lymphocyte proliferative response under H-2-linked Ir gene control. J Immunol. 1978 Sep; 121(3):866-8. PMID: 99478.
      View in: PubMed
    279. Twining SS, Atassi MZ. Antibody-combining sites can be mimicked synthetically. Surface-simulation synthesis of the immunoglobulin new combining site to the gamma-hydroxyl derivative of vitamin K1. J Biol Chem. 1978 Aug 10; 253(15):5259-62. PMID: 670193.
      View in: PubMed
    280. Atassi MZ, Smith JA. A proposal for the nomenclature of antigenic sites in peptides and proteins. Immunochemistry. 1978 Aug; 15(8):609-10. PMID: 83294.
      View in: PubMed
    281. Atassi MZ, Lee CL. The precise and entire antigenic structure of native lysozyme. Biochem J. 1978 May 1; 171(2):429-34. PMID: 656054; PMCID: PMC1183972.
    282. Atassi MZ, Lee CL. Boundary refinement of the lysozyme antigenic site around the disulphide bond 6-127 (site 1) by 'surface-simulation' synthesis. Biochem J. 1978 May 1; 171(2):419-27. PMID: 656053; PMCID: PMC1183971.
    283. Nureddin A, Atassi MZ. Differentiation of the contribution of the two subunits of lutropin to its in vivo activity. Biochim Biophys Acta. 1978 Mar 28; 533(1):257-62. PMID: 565219.
      View in: PubMed
    284. Paull BR, Gleich GJ, Atassi MZ. Separation of active subunits of ragweed antigen E. Immunochemistry. 1978 Mar; 15(3):199-202. PMID: 646866.
      View in: PubMed
    285. Kazim AL, Atassi MZ. Production of autoantibodies by immunization with rabbit myglobin. Immunochemistry. 1978 Jan; 15(1):67-70. PMID: 624563.
      View in: PubMed
    286. Atassi MZ, Kazim AL. First consequences of the determination of the entire antigenic structure of sperm-whale myoglobin. Adv Exp Med Biol. 1978; 98:19-40. PMID: 82383.
      View in: PubMed
    287. Stavitsky AB, Atassi MZ, Gooch GT, Manderino GL, Harold WW, Pelley RP. In vitro responses of myoglobin-primed lymph node cells to myoglobin and myoglobin synthetic antigenic peptides. Adv Exp Med Biol. 1978; 98:199-219. PMID: 82384.
      View in: PubMed
    288. Atassi MZ. The precise and entire antigenic structure of lysozyme: implications of surface-simulation synthesis and the molecular features of protein antigenic sites. Adv Exp Med Biol. 1978; 98:41-99. PMID: 82389.
      View in: PubMed
    289. Atassi MZ, Zablocki W. Can an antibody-combining site be mimicked synthetically? The possible surface simulation synthesis of two antibody-combining sites complementary to two antigenic sites of lysozyme. J Biol Chem. 1977 Dec 25; 252(24):8784-7. PMID: 925023.
      View in: PubMed
    290. Lee CL, Atassi MZ. Enzymic and immunochemical properties of lysozyme. XIX. Definition of the direction and conformational restrictions of the antigenic site around the disulfide bonds 64-80 and 76-94 (site 2) by 'surface-simulation' synthesis. Biochim Biophys Acta. 1977 Dec 20; 495(2):354-68. PMID: 73386.
      View in: PubMed
    291. Lee CL, Atassi MZ. Enzymic and immunochemical properties of lysozyme. Accurate definition of the antigenic site around the disulphide bridge 30-115 (site 3) by 'surface-simulation' synthesis. Biochem J. 1977 Dec 1; 167(3):571-81. PMID: 603622; PMCID: PMC1183703.
    292. Kazim AL, Atassi MZ. Prediction and conformation by synthesis of two antigenic sites in human haemoglobin by extrapolation from the known antigenic structure of sperm-whale myoglobin. Biochem J. 1977 Oct 1; 167(1):275-8. PMID: 73374; PMCID: PMC1183645.
    293. Kazim AL, Atassi MZ. Antibodies against protein antigenic sites that are identical in the homologous protein of the immunized animal. Autoreactivity in rabbits of antibodies to sperm-whale myoglobin. Biochim Biophys Acta. 1977 Sep 27; 494(1):277-82. PMID: 71166.
      View in: PubMed
    294. Habeeb AF, Atassi MZ. Immunochemistry of serum albumin--IV. Immunochemical cross-reaction of fragments from the first third and the last third of bovine serum albumin. Immunochemistry. 1977 Jun; 14(6):449-57. PMID: 328378.
      View in: PubMed
    295. Atassi MZ. Chemical strategy for studying the antigenic structures of disulfide-containing proteins: hen egg-white lysozyme as a model. Adv Exp Med Biol. 1977; 86A:89-137. PMID: 72492.
      View in: PubMed
    296. Lee CL, Atassi MZ. Delineation of the third antigenic site of lysozyme by application of a novel 'surface-simulation' synthetic approach directly linking the conformationally adjacent residues forming the site. Biochem J. 1976 Oct 1; 159(1):89-93. PMID: 999647; PMCID: PMC1164041.
    297. Habeeb AF, Atassi MZ. A fragment comprising the last third of bovine serum albumin which accounts for almost all the antigenic reactivity of the native protein. J Biol Chem. 1976 Aug 10; 251(15):4616-21. PMID: 59728.
      View in: PubMed
    298. Lee CL, Pai RC, Atassi MZ. Enzymic and immunochemical properties of lysozyme--XV. Delineation of the reactive site around the two central disulfides by immunochemical studies of novel synthetic peptides that contain diglycyl bridges instead of disulfides. Immunochemistry. 1976 Aug; 13(8):681-7. PMID: 965036.
      View in: PubMed
    299. Atassi MZ, Habeeb AF, Lee CL. Immunochemistry of serum albumin--II. Isolation and characterization of a fragment from the first third of bovine serum albumin carrying almost all the antigenic reactivity of the protein. Immunochemistry. 1976 Jun; 13(6):547-55. PMID: 950247.
      View in: PubMed
    300. Atassi MZ, Lee CL, Pai RC. Enzymic and immunochemical properties of lysozyme. XVI. A novel synthetic approach to an antigenic reactive site by direct linkage of the relevant conformationally adjacent residues constituting the site. Biochim Biophys Acta. 1976 Apr 14; 427(2):745-51. PMID: 57805.
      View in: PubMed
    301. Atassi MZ, Zablocki W. Conformation, enzymic activity, and immunochemistry of a lysozyme derivative modified at tryptophan 123 by reaction with 2,3-dioxo-5-indolinesulfonic acid. J Biol Chem. 1976 Mar 25; 251(6):1653-8. PMID: 1254590.
      View in: PubMed
    302. Atassi MZ, Koketsu J, Habeeb AF. Enzymic and immunochemical properties of lysozyme. XIII. Accurate delineation of the reactive site around the disulfide 6-127 by immunochemical study of beta-propiolactone lysozyme derivative and of synthetic disulfide peptides. Biochim Biophys Acta. 1976 Feb 20; 420(2):358-75. PMID: 943182.
      View in: PubMed
    303. Atassi MZ, Li Lee C. Enzymic and immunochemical properties of lysozyme-XII. Delineation of the reactive site around the two central disulfides by immunochemical and conformational studies of derivatives of the two-disulfide peptide. Immunochemistry. 1976 Jan; 13(1):7-14. PMID: 943372.
      View in: PubMed
    304. Stavitsky AB, Atassi MZ, Gooch GT, Pelley RP, Harold WW. In vitro responses of primed rabbit lymph node cells to myoglobin and its synthetic antigenic peptides: production of macrophage inhibitory factor and antibody to myoglobin. Immunochemistry. 1975 Dec; 12(12):959-65. PMID: 767252.
      View in: PubMed
    305. Lee CL, Atassi MZ. Enzymic and immunochemical properties of lysozyme. XI. Conformation and immunochemistry of the two-disulfide peptide and the tryptophan and lysine residues in its antigenic reactivity. Biochim Biophys Acta. 1975 Oct 20; 405(2):464-74. PMID: 1180968.
      View in: PubMed
    306. Atassi MZ, Suliman AM, Habeeb AF. Enzymic and immunochemical properties of lysozyme. X. Conformation, enzymic activity and immunochemistry of lysozyme reduced at two carboxyl groups. Biochim Biophys Acta. 1975 Oct 20; 405(2):452-63. PMID: 241414.
      View in: PubMed
    307. Atassi MZ, Pai RC. Immunochemistry of sperm-whale myoglobin--XXII. Accurate delineation of the single reactive region in sequence 103-120 by immunochemical studies of synthetic peptides: the complete antigenic structure of the protein. Immunochemistry. 1975 Sep; 12(9):735-40. PMID: 53190.
      View in: PubMed
    308. Li Lee C, Atassi MZ, Habeeb AF. Enzymic and immunochemical properties of lysozyme. IX. Conformation and immunochemistry of derivatives succinylated at certain lysine residues. Biochim Biophys Acta. 1975 Aug 19; 400(2):423-32. PMID: 1164516.
      View in: PubMed
    309. Atassi MZ. Antigenic structure of myoglobin: the complete immunochemical anatomy of a protein and conclusions relating to antigenic structures of proteins. Immunochemistry. 1975 May; 12(5):423-38. PMID: 53189.
      View in: PubMed
    310. Pai RC, Atassi MZ. Immunochemistry of sperm-whale myoglobin--XX. Accurate delineation of the single reactive region in sequence 80-103 by immunochemical studies of synthetic peptides. Immunochemistry. 1975 Apr; 12(4):285-90. PMID: 53185.
      View in: PubMed
    311. Atassi MZ, Zablocki W. 2,3-Dioxo-5-indolinesulfonic acid, a new highly specific reagent for modification of tryptophan in peptides and proteins. Biochim Biophys Acta. 1975 Mar 28; 386(1):233-8. PMID: 1125271.
      View in: PubMed
    312. Atassi MZ, Nakhleh ET. Conformational studies on modified proteins and peptides. IX. Conformation and immunochemistry of hemoglobin reduced at some carboxyl groups by diborane. Biochim Biophys Acta. 1975 Jan 30; 379(1):1-12. PMID: 1115790.
      View in: PubMed
    313. Atassi MZ, Rosemblatt MC. Conformation of lysozyme derivatives modified at two carboxyl groups. J Biol Chem. 1974 Aug 10; 249(15):4802-6. PMID: 4846749.
      View in: PubMed
    314. Atassi MZ, Rosemblatt MC, Habeeb AF. Enzymic and immunochemical properties of lysozyme--VIII. Modification of two carboxyl groups and their role in the antigenic reactivity. Immunochemistry. 1974 Aug; 11(8):495-500. PMID: 4142452.
      View in: PubMed
    315. Habeeb AF, Atassi MZ, Lee CL. Peptides with strong immunochemical inhibitory activity from bovine serum albumin. Application of a novel approach. Biochim Biophys Acta. 1974 Apr 11; 342(2):389-95. PMID: 4857598.
      View in: PubMed
    316. Koketsu J, Atassi MZ. Immunochemistry of sperm-whale myoglobin. XIX. Accurate delineation of the single reactive region in sequence 54-85 by immunochemical study of synthetic peptides. Biochim Biophys Acta. 1974 Mar 14; 342(1):21-9. PMID: 4824925.
      View in: PubMed
    317. Perlstein MT, Atassi MZ. Immunochemistry of sperm whale myoglobin. XV. Accurate delineation of the single antigenic reactive region in sequence 1-55 of myoglobin by chemical derivatives of the peptide carrying the region: conclusions relating to antigenic structures of proteins. Immunochemistry. 1974 Feb; 11(2):63-70. PMID: 4822859.
      View in: PubMed
    318. Koketsu J, Atassi MZ. Immunochemistry of sperm-whale myoglobin. XVI. Accurate delineation of the single region in sequence 1-55 by immunochemical studies of synthetic peptides. Some conclusions concerning antigenic structures of proteins. Immunochemistry. 1974 Jan; 11(1):1-8. PMID: 4855726.
      View in: PubMed
    319. Atassi MZ, Perlstein MT, Staub DJ. Immunochemistry of sperm-whale myoglobin. XVII. Conformation and immunochemistry of derivatives modified at lysines 98, 140 and 145 by reaction with 3,3-tetramethyleneglutaric anhydride. Biochim Biophys Acta. 1973 Dec 6; 328(2):278-88. PMID: 4204632.
      View in: PubMed
    320. Koketsu J, Atassi MZ. Immunochemistry of sperm-whale myoglobin. 18. Accurate delineation of the single reactive region in sequence 120-153 by study of synthetic peptides. Biochim Biophys Acta. 1973 Dec 6; 328(2):289-302. PMID: 4798146.
      View in: PubMed
    321. Habeeb AF, Lee CL, Atassi MZ. Conformational studies on modified proteins and peptides. VII. Conformation of epsilon-prototoxin and epsilon-toxin from Clostridium perfringens. Conformational changes associated with toxicity. Biochim Biophys Acta. 1973 Oct 18; 322(2):245-50. PMID: 4358084.
      View in: PubMed
    322. Atassi MZ, Perlstein MT. Immunochemistry of sperm whale myoglobin. XIV. Role of histidines 12 and 24 in the antigenic structure. Immunochemistry. 1973 Sep; 10(9):601-6. PMID: 4758987.
      View in: PubMed
    323. Lee CL, Atassi MZ. Conformation and immunochemistry of methylated and carboxymethyulated derivatives of lysozyme. Biochemistry. 1973 Jul 3; 12(14):2690-5. PMID: 4736411.
      View in: PubMed
    324. Atassi MZ, Rosenthal AF, Vargas L. Sterically selective reduction of protein carboxyl groups by disiamylborane or by 9-borabicylo(3,3,1)nonane. Biochim Biophys Acta. 1973 Apr 20; 303(2):379-84. PMID: 4710241.
      View in: PubMed
    325. Atassi MZ, Habeeb AF, Ando K. Enzymic and immunochemical properties of lysozyme. VII. Location of all the antigenic reactive regions. A new approach to study immunochemistry of tight proteins. Biochim Biophys Acta. 1973 Mar 23; 303(1):203-9. PMID: 4121914.
      View in: PubMed
    326. Andres SF, Atassi MZ. Immunochemistry of sperm-whale myoglobin. Conformation and immunochemistry of derivatives prepared by reaction with diazonium-1H-tetrazole. Evaluation of the specificity of the reagent. Biochemistry. 1973 Feb 27; 12(5):942-7. PMID: 4631371.
      View in: PubMed
    327. M.Z. Atassi. Reaction of amino acids and proteins with trichloroisocyanuric acid. Tetrahedron Letters. 1973; 14(49):4893-4896.
    328. Atassi MZ. 3rd International Convocation of Immunology. Specific Receptors of Antigens and Cells (Edited by Pressman D, Tomasi TB, Grossberg AL, Mohn JF and Rose NR). Antigenic Structures of Proteins Inferred From Myoglobin as the First Protein Whose Antigenic Structure has Reached Completion. 1973; 118-136.
    329. Atassi MZ, Singhal RP. Immunochemistry of sperm whale myoglobin. XI. Modification of two glutamic acid residues and their role in the antigenic reactivity. Immunochemistry. 1972 Nov; 9(11):1057-66. PMID: 4627697.
      View in: PubMed
    330. Atassi MZ, Perlstein MT. Immunochemistry of sperm-whale myoglobin. Conformation and immunochemistry of derivative reduced at some carboxyl groups by diborane. Biochemistry. 1972 Oct 10; 11(21):3984-90. PMID: 4116928.
      View in: PubMed
    331. Atassi MZ, Singhal RP. Conformational studies on modified proteins and peptides. V. Conformation of myoglobin derivatives modified at two carboxyl groups. J Biol Chem. 1972 Sep 25; 247(18):5980-6. PMID: 5066543.
      View in: PubMed
    332. Atassi MZ, Perlstein MT, Rosemblatt MC, Rocek P. Fully automated simple analytical peptide chromatography on the amino acid analyzer at the 10- 8 mole level. Anal Biochem. 1972 Sep; 49(1):164-72. PMID: 4673186.
      View in: PubMed
    333. Atassi MZ, Suliman AM, Habeeb AF. Enzymic and immunochemical properties of lysozyme. VI. Conformation, enzymic activity and immunochemistry of derivatives modified at arginine residues. Immunochemistry. 1972 Sep; 9(9):907-20. PMID: 4116340.
      View in: PubMed
    334. Atassi MZ, Habeeb AF. [49] Reaction of proteins with citraconic anhydride. Methods Enzymol. 1972; 25:546-53. PMID: 23014438.
      View in: PubMed
    335. M.Z. Atassi, M.T. Perlstein. Reaction of methionine with boron tribromide and boron triiodide. Tetrahedron Letters. 1972; Volume 13(19):1861-1863.
    336. Atassi MZ, Saplin BJ. Immunochemistry of sperm whale myoglobin. X. Regions responsible for immunochemical cross-reaction with finback whale myoglobin. Some general conclusions concerning immunochemical cross-reaction of proteins. Biochemistry. 1971 Dec 7; 10(25):4740-7. PMID: 4110827.
      View in: PubMed
    337. Habeeb AF, Atassi MZ. Enzymic and immunochemical properties of lysozyme. V. Derivatives modified at lysine residues by guanidination, acetylation, succinylation or maleylation. Immunochemistry. 1971 Nov; 8(11):1047-59. PMID: 5003271.
      View in: PubMed
    338. Atassi MZ, Perlstein MT, Habeeb AF. Conformational studies on modified proteins and peptides. IV. Conformation of lysozyme derivatives modified at tyrosine or at tryptophan residues. J Biol Chem. 1971 May 25; 246(10):3291-6. PMID: 5574399.
      View in: PubMed
    339. Singhal RP, Atassi MZ. Immunochemistry of sperm whale of myoglobin. IX. Specific interaction of peptides obtained by cleavage at arginine peptide bonds. Biochemistry. 1971 May 11; 10(10):1756-62. PMID: 4105026.
      View in: PubMed
    340. Habeeb AF, Atassi MZ. Enzymic and immunochemical properties of lysozyme. IV. Demonstration of conformational differences between alpha-lactalbumin and lysozyme. Biochim Biophys Acta. 1971 Apr 27; 236(1):131-41. PMID: 5103656.
      View in: PubMed
    341. Perlstein MT, Atassi MZ, Cheng SH. Desulfurization of sulfur amino acids and proteins with Raney nickel. Biochim Biophys Acta. 1971 Apr 27; 236(1):174-82. PMID: 5577457.
      View in: PubMed
    342. Atassi MZ. Immunochemistry of sperm whale myoglobin. VI. Preparation and conformational analysis of eight mammalian myoglobins. Biochim Biophys Acta. 1970 Dec 22; 221(3):612-22. PMID: 5499445.
      View in: PubMed
    343. Atassi MZ, Tarlowski DP, Paull JH. Immunochemistry of sperm whale myoglobin. VII. Correlation of immunochemical cross-reaction of eight myoglobins with structural similarity and its dependence on conformation. Biochim Biophys Acta. 1970 Dec 22; 221(3):623-35. PMID: 5499446.
      View in: PubMed
    344. Habeeb AF, Atassi MZ. Enzymic and immunochemical properties of lysozyme. Evaluation of several amino group reversible blocking reagents. Biochemistry. 1970 Dec 8; 9(25):4939-44. PMID: 5480159.
      View in: PubMed
    345. Singhal RP, Atassi MZ. Conformational studies on modified proteins and peptides. Conformation of peptides with intact and overlapping helices obtained by cleavage of myoglobin at proline peptide bonds. Biochemistry. 1970 Oct 27; 9(22):4252-9. PMID: 5528745.
      View in: PubMed
    346. Atassi MZ, Singhal RP. Conformational studies on modified proteins and peptides. 3. Conformation of peptides obtained by cleavage of myoglobin at arginine peptide bonds. J Biol Chem. 1970 Oct 10; 245(19):5122-8. PMID: 5528241.
      View in: PubMed
    347. Atassi MZ, Singhal RP. Immunochemistry of sperm whale myoglobin. 8. Specific interaction of peptides obtained by cleavage at proline peptide bonds. Biochemistry. 1970 Sep 29; 9(20):3854-61. PMID: 5501645.
      View in: PubMed
    348. Andres SF, Atassi MZ. Conformational studies on modified proteins and peptides. Artificial myoglobins prepared with modified and metalloporphyrins. Biochemistry. 1970 May 26; 9(11):2268-75. PMID: 5424201.
      View in: PubMed
    349. Atassi MZ, Habeeb AF, Rydstedt L. Lack of immunochemical cross-reaction between lysozyme and alpha-lactalbumin and comparison of their conformations. Biochim Biophys Acta. 1970 Jan 20; 200(1):184-7. PMID: 5410717.
      View in: PubMed
    350. Atassi MZ. Immunochemistry of sperm whale myoglobin. V. Specific modification of the methionine residues with beta-propiolactone. Immunochemistry. 1969 Nov; 6(6):801-10. PMID: 5361496.
      View in: PubMed
    351. Atassi MZ, Thomas AV. Immunochemistry of sperm whale myoglobin. IV. The role of the arginine residues in the conformation and differentiation of their roles in the antigenic reactivity. Biochemistry. 1969 Aug; 8(8):3385-94. PMID: 4980193.
      View in: PubMed
    352. Atassi MZ. Nitration of the vinyl groups of ferriheme. Biochim Biophys Acta. 1969 May 6; 177(3):663-5. PMID: 5787258.
      View in: PubMed
    353. Atassi MZ, Habeeb AF. Enzymic and immunochemical properties of lysozyme. I. Derivatives modified at tyrosine. Influence of nature of modification on activity. Biochemistry. 1969 Apr; 8(4):1385-93. PMID: 4979752.
      View in: PubMed
    354. Atassi MZ, Rosenthal AF. Specific reduction of carboxyl groups in peptides and proteins by diborane. Biochem J. 1969 Feb; 111(4):593-601. PMID: 5774482; PMCID: PMC1187580.
    355. Atassi MZ, Skalski DJ. Immunochemistry of some artificial human hemoglobins. Immunochemistry. 1969 Jan; 6(1):25-34. PMID: 4974991.
      View in: PubMed
    356. Atassi MZ. Immunochemistry of sperm whale myoglobin. 3. Modification of the three tyrosine residues and their role in the conformation and differentiation of their roles in the antigenic reactivity. Biochemistry. 1968 Sep; 7(9):3078-85. PMID: 5684334.
      View in: PubMed
    357. Atassi MZ, Saplin BJ. Immunochemistry of sperm whale myoglobin. I. The specific interaction of some tryptic peptides and of peptides containing all the reactive regions of the antigen. Biochemistry. 1968 Feb; 7(2):688-98. PMID: 4966930.
      View in: PubMed
    358. Taubman MA, Atassi MZ. Reaction of beta-propiolactone with amino acids and its specificity for methionine. Biochem J. 1968 Feb; 106(4):829-34. PMID: 5637366; PMCID: PMC1198586.
    359. Atassi MZ, Caruso DR. Immunochemistry of sperm whale myoglobin. II. Modification of the two tryptophan residues and their role in the conformation and antigen-antibody reaction. Biochemistry. 1968 Feb; 7(2):699-705. PMID: 5689421.
      View in: PubMed
    360. Rosenthal AF, Atassi MZ. Specific reduction of carboxyl groups in peptides. Biochim Biophys Acta. 1967 Oct 23; 147(2):410-2. PMID: 6073055.
      View in: PubMed
    361. Atassi MZ. Immunochemistry of sperm-whale myoglobins prepared with various modified porphyrins and metalloporphyrins. Biochem J. 1967 Apr; 103(1):29-35. PMID: 6068005; PMCID: PMC1270364.
    362. Atassi MZ. Specific cleavage of tryptophyl peptide bonds with periodate in sperm whale myoglobin. Arch Biochem Biophys. 1967 Apr; 120(1):56-9. PMID: 4292758.
      View in: PubMed
    363. Atassi MZ. Periodate oxidation of sperm-whale myoglobin and the role of the methionine residues in the antigen-antibody reaction. Biochem J. 1967 Feb; 102(2):478-87. PMID: 4291493; PMCID: PMC1270269.
    364. Atassi MZ. Reaction of myoglobin with 3,3-tetramethyleneglutaric anhydride. Biochem J. 1967 Feb; 102(2):488-91. PMID: 6029606; PMCID: PMC1270270.
    365. Atassi MZ. Significance of the amino acid composition of proteins. 1. Composition of hemoglobins and myoglobins in relation to their structure, function and evolution. J Theor Biol. 1966 Jul; 11(2):227-41. PMID: 5965488.
      View in: PubMed
    366. Atassi MZ. Role of the amino groups and C-terminal of sperm-whale myoglobin in the antigen-antibody reaction. Nature. 1966 Mar 19; 209(5029):1209-11. PMID: 5956305.
      View in: PubMed
    367. Atassi MZ, Cacciotti LR. Infra-red spectral analysis of the apoproteins of some haemoglobins and myoglobins. Nature. 1966 Mar 19; 209(5029):1211-3. PMID: 5956306.
      View in: PubMed
    368. Atassi MZ, Saplin BJ. Studies on myoglobin from the finback whale (Balaenoptera physalus). Preparation, physicochemical and immunochemical characterization, differentiation from sperm-whale myoglobin, amino acid composition and end-terminal analyses. Biochem J. 1966 Jan; 98(1):82-93. PMID: 4957175; PMCID: PMC1264798.
    369. Atassi MZ, Brown RK, McEwan M. Immunochemical studies of hemoglobin and the role of the sulfhydryl groups. Immunochemistry. 1965 Dec; 2(4):379-89. PMID: 4957198.
      View in: PubMed
    370. ATASSI MZ, GANDHI SK. AN EMPIRICAL FORMULA FOR CALCULATING MOLECULAR WEIGHTS OF PROTEINS. Naturwissenschaften. 1965 May; 52:259. PMID: 14305699.
      View in: PubMed
    371. Atassi MZ. Chemical studies on haemoglobins A1 and A0. Biochem J. 1964 Oct; 93(1):189-97. PMID: 5838097; PMCID: PMC1206199.
    372. ATASSI MZ. PROPERTIES OF COMPONENTS OF MYOGLOBIN OF THE SPERM WHALE. Nature. 1964 May 2; 202:496-8. PMID: 14167838.
      View in: PubMed
    373. ATASSI MZ, BARKER SA, STACEY M. Neuraminic acid and its relation to chronic bronchitis. V. Glass column electrophoresis of sputum. Clin Chim Acta. 1962 Sep; 7:706-9. PMID: 13965326.
      View in: PubMed
    374. ATASSI MZ, BARKER SA, STACEY M. Neuraminic acid and its relation to chronic bronchitis. IV. Isolation of homogeneous mucoproteins. Clin Chim Acta. 1962 Jul; 7:588-91. PMID: 13863069.
      View in: PubMed
    375. ATASSI MZ, BARKER SA, HOUGHTON LE, MULLARD KS. Mucoproteins of bronchial mucus. Nature. 1961 Dec 30; 192:1269-70. PMID: 13863068.
      View in: PubMed
    376. AMIR SM, ATASSI MZ, BARKER SA, BRIMACOMBE JS, KEITH MC. Some Tetrahydropyranyl Derivatives of Glycine, Serine and Urea. Nature. 1961 Dec 16; 192(4807):1069-70. PMID: 23251946.
      View in: PubMed
    377. ATASSI MZ, BARKER SA, STACEY M. Neuraminic acid and its relation to chronic bronchitis. III. Carbohydrate constituents of sputum. Clin Chim Acta. 1959 Nov; 4:823-7. PMID: 13794934.
      View in: PubMed
    378. ATASSI MZ, BARKER SA, HOUGHTON LE, STACEY M. Neuraminic acid and its relation to chronic bronchitis. II. Clin Chim Acta. 1959 Sep; 4:741-7. PMID: 13794933.
      View in: PubMed
    ATASSI's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _